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ABSTRACT 
 
Termination of transcription is an important, but poorly understood, cellular process. 
RNA polymerase II (Pol II) terminates coding transcripts and non-coding transcripts 
(ncRNAs) through two distinct mechanisms in yeast. In the non-poly(A) dependent 
pathway, Nrd1 and Nab3 bind to their recognition sites on the nascent RNA of ncRNAs 
to cause termination. This is done through an unknown mechanism, but is known to 
involve the RNA-DNA helicase Sen1. In our first study, we have mapped Pol II 
distribution before and after depletion of different termination factors. This was done, by 
depleting each factor from the nucleus and then using PAR-CLIP to assess the position of 
Pol II. Nrd1 depletion leads to widespread runaway transcription at non-poly(A) 
terminators. In contrast, depletion of Sen1 or Ysh1, an endonuclease involved in the 
poly(A) dependent pathway, does not lead to elevated readthrough transcription. These 
differences allowed us to map all the non-poly(A) termination regions throughout the 
yeast genome. Our second study follows the human homolog of Nrd1, RBM16. RBM16 
shares a common protein domain architecture and a conserved CTD interacting domain 
with Nrd1. Although it is unclear whether there is a similar non-poly(A) termination 
pathway in human cells, we show that there are at least similarities between the classes of 
RNAs that are bound to both Nrd1 and RBM16. The final study focuses on the unique 
methodologies used to analyze PAR-CLIP datasets. It describes computer programs and 
bioinformatic pipelines written to provide answers to basic questions based on PAR-
CLIP data. The functions created to answer these questions could be applicable to a wide 
variety of data. The studies presented here provide a foundation so that fundamental 
mechanisms of termination can be elucidated. 
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RNA Polymerase II (Pol II) is responsible for all messenger RNA (mRNA) and some 
non-coding RNA (ncRNA) transcription in eukaryotes. The proteins involved, and the 
time at which they bind, can define the cycle of transcription. Recruitment and initiation 
of Pol II on the DNA template is the first step. This is closely followed by elongation of 
the nascent RNA and, eventual termination of the transcript. The cycle of transcription 
has been extensively studied and reviewed (Barrero and Malik, 2013; Shandilya and 
Roberts, 2012; Svetlov and Nudler, 2013).  Proper termination of Pol II is essential to 
maintaining a pool of free enzyme and to prevent Pol II from interfering with 
downstream genes (Kuehner et al., 2011; Mischo and Proudfoot, 2013). This could 
happen through collision with oncoming Pol II or dislodging transcription factors on the 
downstream DNA template (Castelnuovo et al., 2013; Cloutier et al., 2013; Shearwin et 
al., 2005). In yeast, Pol II termination has been shown to provide a regulatory purpose 
through premature termination of certain genes (Creamer, 2011; Kuehner and Brow, 
2008; Thiebaut et al., 2008). 
 The C-terminal domain (CTD) of Pol II contains a heptad repeat that acts a 
scaffold for protein recruitment during the transcriptional cycle (Buratowski, 2009). The 
consensus sequence (YSPTSPS) of this CTD is conserved from yeast to mammals. Each 
repeat of the CTD is modified during the transcription cycle to reflect the state of Pol II 
transcription (Chapman et al., 2007; Zhang and Corden, 1991). This “CTD Code” is a set 
of phosphorylation and other post-translational modifications that alter which sets of 
proteins are bound to the scaffold and, ultimately, influence Pol II transcription 
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(Buratowski, 2009; Carroll et al., 2007; Komarnitsky et al., 2000; Nedea et al., 2003). 
The most well understood part of the CTD code is phosphorylation of serine residues 
within the heptad repeat. After initiation of Pol II on the DNA template and early 
elongation, there is an abundance of phosphorylation on the fifth serine (Ser5) in the 
tandem repeats. At the 3’ end of the template, there is more phosphorylation of the 
second serine (Ser2). These patterns allow the CTD to be a dynamic scaffold for many 
different co-transcriptional machines (Corden, 2013; Hsin and Manley, 2012; Napolitano 
et al., 2014). 
 Pol II pervasively transcribes many ncRNAs throughout the yeast genome 
(Berretta and Morillon, 2009; Jacquier, 2009; Jensen et al., 2013). These ncRNAS can be 
categorized into three subclasses: Cryptic Unstable Transcripts (CUTs) that are readily 
degraded by the nuclear exosome (Arigo et al., 2006; Davis and Ares, 2006; Gudipati et 
al., 2012; Neil et al., 2009; Thiebaut et al., 2006; Wyers et al., 2005), Stable 
uncharacterized transcripts (SUTs) that do not rely on the nuclear exosome to be 
observed (Xu et al., 2009) and Xrn1-dependent transcripts (XUTs) that are only found in 
the absence of the nuclease Xrn1 (van Dijk et al., 2011). 
 In yeast, termination of mRNAs and some SUTs happen through the cleavage and 
polyadenylation (pA) machinery. Loosely conserved sequences at the 3’ end of the 
transcript act as signal for binding of the CF1 complex, which leads to the recruitment of 
the pA machinery and termination of the transcript (Kuehner et al., 2011; Mischo and 
Proudfoot, 2013). The mechanism of this action has yet to be elucidated. snoRNA and 
other ncRNA termination happens through the Nrd1-Nab3-Sen1 (NNS) pathway. Unlike 
pA-mediated termination, the NNS pathway binds early in transcription when Ser5 
	   3	  
phosphorylation of the CTD is high (Chinchilla et al., 2012). Similarly to pA-termination, 
Nrd1 and Nab3 recognized RNA sequences elements downstream of certain ncRNAs 
(Carroll et al., 2007; Carroll et al., 2004; Creamer, 2011; Porrua et al., 2012; Steinmetz et 
al., 2001; Steinmetz et al., 2006; Wlotzka et al., 2011). This leads to recruitment of the 
DNA/RNA helicase Sen1 as well as the nuclear exosome (Conrad et al., 2000; Steinmetz 
and Brow, 1996, 1998; Steinmetz et al., 2001; Ursic et al., 2004). How these factors work 
together to direct termination and turnover is not well understood. 
 Two possible mechanisms for transcriptional termination have been proposed. In 
the first, the exposed uncapped 5’ end of the nascent transcript, after cleavage from the 
poly-A site, recruits a 5’ -> 3’ exonuclease. In yeast, this protein is Rat1 while in 
metazoans the protein is Xrn2 (Kim et al., 2004; West et al., 2004). In this model, Pol II 
is already paused downstream of the poly-A site. The exonuclease degrades the nascent 
RNA until it reaches the stalled Pol II and apparently this facilitates release. This process 
is called the “torpedo” model of transcription termination. The other commonly accepted 
model of transcription termination is referred to as the allosteric model  
(Logan et al., 1987). In this model, it is not the outside action of an exonuclease that 
causes the release but the pausing and binding of certain factors that induce an allosteric 
change in Pol II, facilitating its release from the DNA template on non-poly(A) 
transcripts.  Pcf11, a member of the pA complex, has been shown to dismantle the 
elongation complex in vitro (Zhang and Gilmour, 2006; Zhang et al., 2007) and Nrd1 
may act similarly. The DNA/RNA helicase Sen1 has been proposed to act like the 
bacterial termination factor rho and pry off the elongating Pol II (Brow, 2011; Kim et al., 
1999; Kuehner et al., 2011; Steinmetz and Brow, 1996; Ursic et al., 2004). As there is 
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evidence for both models of transcription termination, a mixture of both of these models 
may be correct. 
 We have previously used a method called Photoactivatable Ribonucleoside-
Enhanced Crosslinking and Immunoprecipitation (PAR-CLIP) to map the binding sites of 
Nrd1, Nab3, Sen1, and Rpb2 throughout the transcriptome (Creamer, 2011; Jamonnak, 
2011).  PAR-CLIP is a method to crosslink RNA bound to specific proteins following the 
incorporation of 4-thiouridine (4TU) or 4-thiouracil (4SU) into the transcriptome (Hafner 
et al., 2010).  4SU is used in yeast because of it can be readily fed into the yeast 
nucleotide salvage pathway and incorporated into RNA. 4TU is substituted for 4SU in 
mammalian cells because these cells do not have the correct uracil 
phosphoribotransferase enzyme for 4SU to be incorporated (Miller et al., 2009). 
Nrd1, Nab3 and Sen1 binding sites were mapped genome-wide as the first step to 
understand more about the NNS pathway (Creamer, 2011). Nrd1 and Nab3 binding sites 
were found, not only at the 3’ end of snoRNA genes, but also at the 5’ end of some 
mRNA genes and antisense to poorly transcribed genes. This allowed us to formulate a 
model by which the NNS pathway binds early in transcription and monitors the nascent 
RNA for binding sites. In this way, the NNS complex may act as a checkpoint for proper 
elongation. In the case of antisense transcripts and some mRNAs, the complex would 
find it’s binding site and terminate the transcript (Creamer, 2011). 
In the first part of these studies, we have used PAR-CLIP to map Pol II globally 
after mutation of both termination pathways in yeast. Although much was learned from 
the binding sites of Nrd1, Nab3, and Sen1 in vivo from purifying their bound RNAs, their 
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global effect on transcription remained untested. This was studied by introducing a new 
system of depleting tagged factors from the nucleus in a time dependent manner termed 
Anchor Away. The anchor away scheme uses the binding of rapamycin to induce export 
of a tagged protein out of the nucleus (Haruki et al., 2008). Using anchor away and Pol II 
PAR-CLIP, we could visualize the affect of termination factor mutation on termination 
globally. The Cramer lab (Munich) published this idea recently, but they used 4TU-seq to 
identify the messages affected by Nrd1 depletion (Schulz et al., 2013). Although, both 
methods use 4TU, we show that they overestimated the effect of Nrd1 mutation because 
their method was confounded by RNA turnover.  We describe a clear definition of 
termination regions based on the amount of readthrough caused by termination factor 
depletion (Schaughency, 2014).   
Poly(A)-mediated termination is fairly conserved in higher eukaryotes, but it is 
unclear whether a pathway similar to the NNS modifies ncRNA transcription. snoRNAs 
are mostly contained within introns of mammalian genes, but the mechanism of snoRNA 
maturation still requires the nuclear exosome (Berndt et al., 2012; Hirose et al., 2003). 
Sen1 has a conserved homolog called Senataxin in mammalian cells (Chen et al., 2006). 
It is unclear whether the putative helicase Senataxin retains a function in processing 
ncRNAs . Although, mutations in senataxin have been implicated in the cause of certain 
rare forms of ALS (Anheim et al., 2009; Bassuk et al., 2007; Chen et al., 2006). Nrd1 
does have two homologs identified through their similarity in protein domain architecture 
and conservation of the CTD interacting domain (CID) (Yuryev et al., 1996). These are 
RBM16 and SFRS15, but little else about their function within the nucleus is known.  
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In the second part of these studies, we looked at the binding of RBM16 
throughout the mammalian transcriptome. Much like the experiments in mapping the 
yeast binding sites in vivo, this is the first step in formulating a model for the action of 
these proteins. We find that RBM16 binds to some protein coding genes, ncRNAs, and 
snoRNAs. These three categories of bound RNAs seem to be conserved from yeast Nrd1. 
This may suggest a similar mechanism of action. Further mutation studies could 
illuminate RBM16’s function within the nucleus. 
For the final part of these studies, we looked at the analyses of PAR-CLIP 
datasets. PAR-CLIP requires a unique set of programs to accommodate its analysis 
problems. There is a T -> C transition when the reverse transcriptase makes the cDNA 
from the crosslinked RNA (Hafner et al., 2010). Although useful in finding exact 
crosslinking sites, it poses problems for correct alignment of these sequences to the 
genome.  This was solved, by allowing mismatches when mapping these datasets. 
Another problem was the normalization PAR-CLIP datasets within an experiment. 
Without normalization of the reads, every dataset would not be comparable to each other. 
The solution was to multiply every read by the amount of reads mapped per 107 reads. 
Unique functions and programs were derived in order to answer basic questions about all 
these PAR-CLIP datasets. Taken together, these studies have extended the knowledge of 
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ABSTRACT 
Yeast RNA polymerase II (Pol II) terminates transcription of coding transcripts through 
the polyadenylation (pA) pathway and non-coding transcripts through the non-
polyadenylation (non-pA) pathway. We have used PAR-CLIP to map the position of Pol 
II genome-wide in living yeast cells after depletion of components of either the pA or 
non-pA termination complexes. We show here that Ysh1, responsible for cleavage at the 
pA site, is required for efficient removal of Pol II from the template.  Depletion of Ysh1 
from the nucleus does not, however, lead to readthrough transcription. In contrast, 
depletion of the termination factor Nrd1 leads to widespread runaway elongation of non-
pA transcripts. Depletion of Sen1 also leads to readthrough at non-pA terminators, but in 
contrast to Nrd1 this readthrough is less processive or more susceptible to pausing. The 
data presented here provide delineation of in vivo Pol II termination regions and highlight 
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AUTHOR SUMMARY 
Transcription termination is an important regulatory event for both non-coding and 
coding transcripts. Using high-throughput sequencing, we have mapped RNA 
Polymerase II’s position in the genome after depletion of termination factors from the 
nucleus. We found that depletion of Ysh1 and Sen1 cause build up of polymerase directly 
downstream of coding and non-coding genes, respectively.  Depletion of Nrd1 causes an 
increase in polymerase that is distributed up to 1,000 bases downstream of non-coding 
genes. The depletion of Nrd1 helped us to identify more than 250 unique termination 
regions for non-coding RNAs.  Within this set of newly identified non-coding 
termination regions, we are further able to classify them based on sequence motif 
similarities suggesting a functional role for different terminator motifs. The role of these 
factors in transcriptional termination of coding and/or non-coding transcripts can be 
inferred from the effect of polymerase’s position downstream of given termination sites. 
This method of depletion and sequencing can be used to further elucidate other factors 
whose importance to transcription has yet to be determined. 
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INTRODUCTION 
 
Termination of RNA Polymerase II (Pol II) transcription plays an essential role in the 
transcription cycle and has been the subject of several recent reviews (Kuehner et al., 
2011; Mischo and Proudfoot, 2013).  Disruption of the elongation complex at terminators 
recycles Pol II maintaining a pool of free enzyme able to compete for unoccupied 
promoters. Correct termination also prevents Pol II from interfering with expression of 
downstream genes either by colliding with oncoming Pol II elongation complexes or by 
dislodging transcription factors from the downstream DNA template (Castelnuovo et al.; 
Cloutier et al., 2013; Shearwin et al., 2005). Termination can also serve a regulatory 
purpose. Several yeast genes are regulated by premature termination (Arigo et al., 2006a; 
Creamer et al., 2011; Kuehner and Brow, 2008) and genes involved in yeast nucleotide 
metabolism are regulated by the choice of alternative transcription start sites, one of 
which leads to premature termination (Kuehner and Brow, 2008; Thiebaut et al., 2008).  
More recent studies have shown that correct termination is also necessary for efficient re-
initiation at the same gene through the formation of a loop between the 3’ and 5’ ends 
(Grzechnik et al., 2014; Tan-Wong et al., 2012). 
In addition to mRNAs, Pol II transcribes a diverse set of non-coding RNAs 
including snoRNA, some snRNAs and several classes of ncRNA with unknown functions. 
In yeast, this pervasive transcription (Berretta and Morillon, 2009; Jacquier, 2009; Jensen 
et al., 2013) falls into several classes. Cryptic unstable transcripts (CUTs) are turned over 
rapidly by the nuclear exosome (Arigo et al., 2006b; Davis and Ares, 2006; Gudipati et 
al., 2012; Neil et al., 2009; Thiebaut et al., 2006; Wyers et al., 2005).  In contrast, another 
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class of yeast ncRNA, termed stable uncharacterized transcripts (SUTs) are observed in 
the presence of an active nuclear exosome (Xu et al., 2009).  
Pol II terminates coding and non-coding transcripts by different mechanisms 
(Buratowski, 2005; Hsin and Manley, 2012; Kim et al., 2006; Kuehner et al., 2011; 
Mischo and Proudfoot, 2013).  Coding transcripts and possibly some SUTs are processed 
at the 3’-end by the cleavage and polyadenylation (pA) machinery. This reaction is 
coupled to termination occurring downstream of the processing site (Kuehner et al., 2011; 
Mischo and Proudfoot, 2013). In contrast, ncRNAs are terminated and processed by an 
alternative pathway that, in yeast, requires the RNA-binding proteins Nrd1 and Nab3 and 
the RNA helicase Sen1 (Conrad et al., 2000; Steinmetz and Brow, 1996, 1998; Steinmetz 
et al., 2001; Ursic et al., 2004).  
Yeast Pol II terminators contain short RNA sequences that bind proteins within 
large complexes associated with the elongating Pol II. Loosely conserved pA signal 
sequences downstream of protein-coding genes bind to components of the CF1 complex 
leading to assembly of the cleavage and polyadenylation machinery (Kuehner et al., 
2011). Termination is coupled to cleavage in a manner that has not yet been completely 
resolved. Non-pA termination components Nrd1 and Nab3 recognize RNA sequence 
elements downstream of snoRNAs and CUTs (Carroll et al., 2007; Carroll et al., 2004; 
Creamer et al., 2011; Porrua et al., 2012; Steinmetz et al., 2001; Steinmetz et al., 2006a; 
Wlotzka et al., 2011) and this leads to the association of a complex that contains the 
DNA/RNA helicase Sen1 and the nuclear exosome (Vasiljeva and Buratowski, 2006).  
The mechanism of termination of these ncRNA transcripts has also not yet been 
determined.  
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Several possible mechanisms for Pol II termination have been proposed. The 
“torpedo” model postulates that cleavage at the pA site exposes an uncapped 5’ end on 
the nascent transcript that acts as a substrate for the 5’  3’ RNA exonuclease Rat1 in 
yeast or Xrn2 in metazoans (Brannan and Bentley, 2012; Kim et al., 2004b; West et al., 
2004). The exonuclease degrades the nascent transcript and upon reaching the Pol II 
elongation complex facilitates termination by an unknown mechanism. Another model 
postulates that an allosteric change in Pol II occurs upon assembly of the pA complex 
(Logan et al., 1987). A member of this complex, Pcf11 has been shown to dismantle an 
elongation complex in vitro (Zhang and Gilmour, 2006; Zhang et al., 2007) and it is 
possible that Nrd1 plays a similar role. The DNA/RNA helicase Sen1 interacts with the 
Pol II CTD (Chinchilla et al., 2012) and has been proposed to act like the bacterial 
termination factor rho and track along the nascent transcript and pry off the elongating 
Pol II (Brow, 2011; Kim et al., 1999; Kuehner et al., 2011; Steinmetz and Brow, 1996; 
Ursic et al., 2004).  Mutation of Sen1 has been shown to lead to readthrough of both 
coding and non-coding transcripts in vivo (Steinmetz et al., 2006b) and in vitro can arrest 
transcription (Porrua and Libri, 2013).  
Part of the uncertainty in delineating termination mechanisms is identifying which 
factors operate at which terminators in vivo. In this study we have used PAR-CLIP to 
map Pol II on the yeast genome in living cells (Creamer et al., 2011; Hafner et al., 2010a, 
b; Jamonnak et al., 2011) after depletion from the nucleus of components of the different 
termination pathways (Haruki et al., 2008).  By comparing the Pol II maps with and 
without nuclear depletion we are able to map the location of termination to narrow 
regions of the genome downstream of coding and non-coding genes. This approach 
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avoids the complexity of using transcripts to map terminators as the effect of RNA 
turnover is eliminated. We show here that depletion of Ysh1, the protein that cleaves 
nascent pre-mRNA transcripts at the pA site, enhances accumulation of Pol II at the 3’-
ends of protein-coding genes. In contrast, both Nrd1 and Sen1 depletion lead to 
readthrough transcription of ncRNAs and our data has allowed us to map the position of 
non-pA termination facilitated by these factors.  
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RESULTS 
Mapping in vivo Pol II termination  
To map in vivo termination we have used the anchor-away (AA) system (Haruki 
et al., 2008) to deplete termination factors from the nucleus.  In this approach rapamycin 
(rap) induces a complex between a protein tagged with a FKBP12-rapamycin binding 
(FRB) domain and an anchor protein tagged with an FKBP12 domain. In our case the 
FKBP12 domain is on the ribosomal protein RPL13A leading to rap-dependent depletion 
of FRB-tagged protein from the nucleus. Previous work has shown that a Pol II subunit 
RPB1-FRB strain shows greater than 90% depletion of Pol II at the PMA1 gene within 40 
min (Fan et al., 2010).  We show here that in NRD1-FRBGFP or YSH1-FRBGFP strains 
that also contain, RPB3-TAGRFP, Nrd1 and Ysh1 are depleted from the nucleus with 
similar kinetics (Figure 1A-B).  We were unable to observe Sen1-FRBGFP because it is 
present only in ~100-2,000 copies per cell.  When over-expressed 10-100-fold from a Gal 
promoter Sen1-FRBGFP is visible and is depleted from the nucleus with similar kinetics 
(Figure 1C). Given the limitations of background signals in live-cell imaging we cannot 
rule out the possibility that some small amount of Nrd1, Ysh1 or Sen1 remain in the 
nucleus. Growth curves show that all three strains grow normally for several divisions 
after administration of rap and we carried out PAR-CLIP analysis well before any 
changes in growth were observed (Figure 2A, shaded box). When cells are plated on 
media containing rap we observe no growth for YSH1-FRB and NRD1-FRB, while SEN1-
FRB grows very slowly (Figure 1D).  
Growing yeast cultures were cross-linked as previously described (Creamer et al., 
2011; Jamonnak et al., 2011) with modifications described in Methods.  Briefly, 4-
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thiouracil (4tU) was added to a growing culture for 15 minutes to allow equilibration of 
uracil pools before the addition of rap.  After thirty minutes of rap treatment cultures 
were irradiated with 365 nm UV for 15 min (Figure 2B). Incubation of yeast cells in 4tU 
does not significantly affect growth during the course of the experiment as cells continue 
to grow beyond the time frame of the cross-linking for at least one more doubling (0.2 
OD600 to 0.7 OD600 as measured by BioTek scanner) indicating that 4tU has a less drastic 
effect on yeast growth than it does in mammalian cells treated for a longer time (Burger 
et al., 2013).   
To map the position of elongating Pol II we isolated Pol II-bound RNA using a 
dual 6xHis-biotin tagged Pol II Rpb2 subunit (Rpb2-HTB) as previously described 
(Creamer et al., 2011).  Duplicate libraries were derived from the RPB2-HTB NRD1-FRB 
strain grown in the presence or absence of rap.  We also created libraries of Rpb2-bound 
RNA from SEN1-FRB and the parental RPB2-HTB strains grown in the presence of rap 
and a single library from YSH1-FRB.  Replicate libraries were multiplexed and sequenced 
by Illumina Hi-seq.  Each library yielded between 15-39 million unique reads (Table 1).  
Biological replicates were strongly correlated (r  > .99) and thus were added together for 
analysis (Figure 3). The WT dataset correlates very well to NET-seq (Churchman and 
Weissman, 2011) and GRO-seq (Pelechano et al., 2010) datasets (Figure 4). Thus, PAR-
CLIP data accurately represents the position of Pol II elongation complexes on the yeast 
genome.  
Ysh1-dependent termination    
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To map pA-dependent termination we carried out PAR-CLIP on Rpb2 after depletion of 
Ysh1, the factor that has been shown to be required for cleavage of the nascent mRNA at 
the GAL7 and CYC1 pA sites (Zhelkovsky et al., 2006).  We reasoned that failure to 
cleave the nascent transcript would prevent Rat1 degradation thus disabling the “torpedo” 
mechanism.  While we cannot rule out the possibility that other factors are depleted along 
with Ysh1 we do observe a failure to cleave at the pA site for several genes (Figure 5). 
The most dramatic effect of Ysh1 depletion is seen in a buildup of reads just downstream 
of the major pA site of highly expressed protein-coding genes (Figure 6A and 2C).  The 
peak of reads is present in most of the highly expressed protein-coding genes as seen in 
figure 6B.  No similar effect is seen downstream of snoRNAs or CUTS.  One surprising 
aspect of Ysh1 depletion is that readthrough Pol II does not extend further downstream 
but seems to pause or terminate within 200 bp of the pA site (Figure 6A). This result 
indicates that Pol II that reads through termination signals fails to elongate but is unable 
to efficiently terminate.   
We do, however, observe several instances of Pol II extending 1 kb or more 
downstream of apparent terminators in response to Ysh1 depletion.  The RNA14 and 
DBP2 genes show an increase of Pol II toward the 3’ end of the coding region indicating 
the presence of a Ysh1-dependent terminator upstream of the main pA site (Figure 6D).  
Rna14p is part of the CF1 complex required for recognition of pA sites (Kuehner et al., 
2011) and previous studies have shown that in addition to the mature 2.2 kb mRNA 
several smaller mRNAs are present under normal conditions (Brendolise et al., 2002; 
Mandart, 1998). The terminator we map in RNA14 is located in the same region as the 3’ 
end of the shorter (1 kb) mRNA (Figure 6D).  
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Dbp2p is a DEAD-box RNA helicase that plays a role in assembly of mRNP 
complexes and in RNA quality control (Cloutier et al., 2012; Ma et al., 2013). The DBP2 
gene is unique in yeast in having a long (1kb) intron localized toward the 3’ end of the 
coding region and previous work has shown that the gene is autoregulated through 
sequences in the intron (Barta and Iggo, 1995).  In Figure 6D we show that depletion of 
Ysh1 leads to an increase in Pol II cross-linking downstream of the intron suggesting the 
presence of an upstream terminator. Consistent with this view polyadenylation sites have 
been mapped to this location in the Dbp2 intron (Moqtaderi et al., 2013; Ozsolak et al., 
2010; Wilkening et al., 2013).  
Nrd1-dependent termination   
Previous work has shown that Nrd1p is required for proper termination of ncRNAs like 
snoRNAs and CUTs as well as premature termination of coding transcripts of genes 
regulated by attenuation (Arigo et al., 2006a; Kuehner and Brow, 2008; Steinmetz et al., 
2001; Thiebaut et al., 2008; Thiebaut et al., 2006; Vasiljeva and Buratowski, 2006; 
Vasiljeva et al., 2008).  Here we show that depletion of Nrd1 in the presence of rap leads 
to readthrough transcription of a large number of these ncRNAs.  Similar results have 
recently been obtained by a different protocol (Schulz et al., 2013).  
To map the position of termination we used an approach similar to that used to 
calculate a travelling ratio (Rahl et al., 2010) or Escape Index (Brannan and Bentley, 
2012; Schulz et al., 2013).  Reads in 500 bp windows upstream and downstream of a 
fixed point were tallied and a ratio of reads in the downstream window to total reads in 
both windows were calculated for that point. This ratio was determined for each point in 
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the genome on both strands for both control and rap treated cells. Subtracting the fraction 
of readthrough of the control data from the rap-treated data resulted in a Readthrough 
Index that allowed us to rank order the regions of the genome showing the highest level 
of Nrd1-dependent readthrough (Table 2).   
Once these regions were identified, we created plots of the difference between the 
reads in the control and reads with rap (Figure 7A). Nrd1 depletion leads to both a 
reduction of Pol II upstream and an increase of Poll II downstream of apparent 
termination sites. This is consistent with previous reports that Pol II pauses prior to 
termination (Gromak et al., 2006; Hyman and Moore, 1993; Kazerouninia et al., 2010; 
Larson et al., 2011).  In the absence of Nrd1, this apparent pause is eliminated and Pol II 
is able to transcribe through the termination site. Fitting this difference plot with a spline 
function allowed us to determine the point at which the difference plot crosses the X-axis.  
We have called this the termination site but this represents the center point of a narrow 
(about 50 nt) region over which Pol II is released from the template.   
In Figure 7A we show the difference plots for snoRNA snR34 and the antisense 
CUT to the LEO1 gene demonstrating how the termination sites were identified.  We 
have carried out this analysis for 49 snoRNAs and for 144 CUTs showing the highest 
level of readthrough transcription (Tables S2 and S3).  Comparing these termination sites 
to the sites determined by Pol II ChIP (Schulz et al., 2013) reveals that 70% of the Schulz 
et al. sites are more than 100 nt downstream of our termination sites and 25% are more 
than 200 nt downstream (Figure 8).  We do not know the reason for this systematic 
discrepancy but the PAR-CLIP analysis has greater resolution than Pol II ChIP and 
unlike ChIP gives strand-specificity. The metagene analysis of the ncRNAs for which we 
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have mapped termination sites is shown in Figure 7B demonstrating a more significant 
increase in readthrough transcription for Nrd1-depletion when compared to the increase 
in readthrough transcription due to Ysh1 depletion (Figure 6A). SnoRNA and CUT Nrd1-
dependent readthrough extends over 500bp and 1 kb, respectively. 
Examining DNA sequences upstream of the termination site for these sets of 
snoRNAs and CUTs revealed an interesting difference in the occurrence of Nrd1 and 
Nab3 binding motifs.  The top hit in the MEME analysis (Bailey et al., 2009) of the top 
27 snoRNA upstream regions (Figure 7C) include the GUA[A/G] sequence previously 
identified as a Nrd1 binding site (Bacikova et al., 2014; Carroll et al., 2007; Carroll et al., 
2004; Creamer et al., 2011; Porrua et al., 2012; Wlotzka et al., 2011).  This analysis also 
identifies a loosely conserved sequence AACUA centered about seven nucleotides 
upstream of the GUA[A/G] sequence that has not previously been reported.  The second 
most significant motif upstream of the snoRNA termination site was the UCUU sequence 
that binds Nab3, consistent with the presence of a Nrd1-Nab3 heterodimer (Carroll et al., 
2007; Conrad et al., 2000). In sequences upstream of CUT terminators the most 
significant hit was UCUUG which contains the previously identified Nab3-binding 
sequence but with a downstream G as has been observed previously (Creamer et al., 
2011; Porrua et al., 2012; Wlotzka et al., 2011).  Among the 144 CUT terminators the 
Nrd1 binding motif was not present above background.  Together, these observations 
suggest a significant difference in the manner of recognition of snoRNA and CUT 
terminators. 
U-rich sequences in the Nrd1-dependent termination region 
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In Figure 9 we show NET-seq (Churchman and Weissman, 2011) and PAR-CLIP data 
demonstrating that Pol II levels decline in the SNR13-TRS31 intergenic region. NET-seq 
reads for several peaks, indicated by bars, are reduced several-fold immediately 
downstream from the 3’-end of the SNR13 gene and more than 6-fold further than 100 nt 
downstream. PAR-CLIP reads from cells grown in the absence of rap decline at the same 
region reaching a minimum at about 150 nt downstream of the SNR13 3’-end. A similar 
correspondence between NET-seq and PAR-CLIP data is seen for other snoRNA genes 
(Figure 10). Taken together, these observations indicate that Pol II normally terminates in 
a Nrd1-dependent fashion in a narrow region located downstream of the snoRNA gene.  
The sequence from this region for SNR13, located from 50 – 150 nt downstream, is 
shown below the figure and a series of runs of U residues is indicated in red.  This is not 
unexpected as intergenic regions in S. cerevisiae are AT-rich.  Sequences of termination 
regions of several antisense CUTs are shown below the SNR13 sequence. In these cases 
we also observe runs of U residues. This is unexpected as these termination regions fall 
within coding regions (on the opposite strand) which in general are not AT-rich.  We 
propose that these U-rich regions constitute part of the non-poly(A) terminator.  
Nrd1 and RNA turnover 
We estimate that SNR13 readthrough transcripts are present at less than one copy 
per cell in wild-type cells and this is consistent with the low level of readthrough 
transcripts seen in the absence of rap in the Northern blot shown in Figure 11A.  Despite 
this low level of steady-state readthrough transcripts we observe significant cross-linking 
to Rpb2 in the region downstream of SNR13 (Figure 11B) even in the presence of Nrd1.  
Presumably the RNA synthesized by these polymerases is rapidly degraded by the 
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nuclear exosome. Figure 11A shows that snR13 readthrough transcripts detected by 
Northern blot or RT-PCR are increased more than 10-fold by 15 min and more than 100-
fold by 30 min of Nrd1 depletion.  However, depletion of Nrd1 results in only a 2-3-fold 
increase in PAR-CLIP signal for Rpb2 (Figure 11B) indicating that depletion of Nrd1 not 
only allows readthrough of ncRNA transcripts but also results in their stabilization by 
uncoupling degradation by the nuclear exosome.  
Our analysis of steady-state RNA levels is consistent with recently published 4tU-
seq data (Schulz et al., 2013).  Figure 11C shows the comparison of our data and that of 
Schulz et al for SNR13 and the upstream RPL27B gene and for the SNR62 and SNR9 
genes.  4tU-seq data show a dramatic increase in SNR13 and SNR62 readthrough 
transcription compared to PAR-CLIP data. The most likely explanation for this difference 
is that 4tU labeling is not completely restricted to nascent transcripts.  Labeling cells for 
six minutes with 4tU allows for multiple rounds of transcription especially for heavily 
transcribed genes like snoRNAs and ribosomal protein genes. The earliest synthesized 
transcripts are subject to processing as is clearly evident in the paucity of reads derived 
from the intron of RPL27B in the 4tU-seq compared to the PAR-CLIP (Figure 11C) and a 
number of other intron-containing genes (Figure 12).  Depletion of Nrd1 does not effect 
all snoRNAs as is seen in Figure 11C where neither PAR-CLIP nor 4tU-seq detect 
appreciable readthrough transcription at SNR9.  
Sen1-dependent termination    
A role for Sen1p in termination of both coding and ncRNA transcripts has been proposed 
(Steinmetz and Brow, 1996; Steinmetz et al., 2001; Steinmetz et al., 2006b). Our current 
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data show that depletion of Sen1 results in no change in the localization of Pol II at the 
3’-ends of most protein-coding genes (Figure 13A) including those previously shown 
(Steinmetz et al., 2006b) to be dependent on Sen1 (Figure 14). Thus, despite our previous 
observation that Sen1 cross-links to these transcripts (Creamer et al., 2011), there is little 
evidence for a role for Sen1 in pA termination.  Sen1 depletion does result in readthrough 
transcription at both snoRNAs and CUTS (Figure 13B-C) which is consistent with 
previous observations (Arigo et al., 2006b; Steinmetz et al., 2001; Thiebaut et al., 2006). 
The pattern of Pol II readthrough in response to Sen1 depletion differs, however, from 
that of Nrd1. Rather than an extended region of readthrough downstream of the 
terminator, Sen1 depletion often results in an increase just downstream by a few hundred 
nucleotides. This type of pattern is seen in Figure 13D for SNR47 and the CUT antisense 
to the COG8 gene and in Figure 15 for several protein-coding genes regulated by Nrd1-
dependent attenuation. Figure 13E compares the percent readthrough downstream of all 
266 non-pA terminators in Sen1 depleted and Nrd1 depleted cells. The percent 
readthrough after Nrd1 depletion is twice that for Sen1 depletion and these values are not 
dominated by a subset of terminators. This observation suggests that Sen1 may play a 
different function than Nrd1 at these genes and that loss of Sen1 results in less processive 
or more pause prone readthrough transcription.   
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DISCUSSION 
In this paper we describe the development and implementation of a technique for 
mapping the position of in vivo Pol II termination. Depletion of components of the yeast 
Pol II termination machinery followed by Pol II cross-linking to nascent RNA has 
allowed the identification of both pA and non-pA termination regions. The site of pA 
termination has been mapped to within a few hundred bases of the pA site as has 
previously been observed for the Cyc1 terminator (Birse et al., 1998). We have identified 
non-pA terminators using an algorithm that identifies points in the genome where Pol II 
readthrough increases in response to Nrd1 depletion.   
While many of the components of both the pA and non-pA termination complexes 
have been identified, the mechanism of termination is still unclear.  Two general models 
have been proposed (Buratowski, 2005; Kuehner et al., 2011; Luo and Bentley, 2004; 
Mischo and Proudfoot, 2013).  The allosteric model proposes a conformational change in 
Pol II that slows elongation (Calvo and Manley, 2001; Logan et al., 1987; Nag et al., 
2006) while the torpedo model proposes that cleavage at the pA site creates a substrate 
for a 5’  3’ exonuclease (Rat1 in yeast and Xrn2 in metazoa) that degrades the nascent 
transcript like a “fuse” and upon reaching elongating Pol II somehow facilitate 
termination (Connelly and Manley, 1988; Kim et al., 2004b; West et al., 2004). Neither 
model adequately explains all experimental observations leading to a hybrid model that 
includes both allosteric and topedo mechanisms (Luo et al., 2006).  
pA Termination 
Our data on Ysh1 depletion supports a two-step pause and release model for termination 
that invokes both allosteric and torpedo mechanisms (Nag et al., 2007). The buildup of 
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Pol II just downstream of the uncleaved pA site suggests that Pol II has paused but is 
deficient in the subsequent release step. This is consistent with a role for Ysh1 in 
providing the substrate for the Rat1 exonuclease that facilitates removal of Pol II from the 
template (Pearson and Moore, 2013).  Ysh1 apparently is not required for the allosteric 
change that results in pausing downstream of the pA site as seen in the lack of  
readthrough at most pA sites. In contrast, mutation of the pA site (Kim et al., 2004a) or 
mutations in RNA14, RNA15, PCF11, CLP1 and GLC7 result in readthrough transcription 
more than 500 nt downstream (Al Husini et al., 2013; Birse et al., 1998; Schreieck et al., 
2014) arguing for a role for these factors in the allosteric change that renders Pol II 
immobilized.  
Depletion of Ysh1 has also revealed several genes that are apparently regulated by 
premature termination through the pA pathway. RNA14 and DBP2 contain pA sites 
upstream from the 3’ pA site. Loss of Ysh1 leads to processive elongation ending at the 
downstream pA site indicating that Ysh1 is required for termination at these upstream 
sites. Why the putative allosteric step does not function efficiently at these upstream sites 
is not clear. Perhaps the phosphorylation pattern of the CTD at these sites precludes the 
assembly of factors like Pcf11.  Alternatively, chromatin structure modification induced 
by the Pol II that elongates through these terminators may suppress normal termination. 
Finally, it is possible that use of the downstream terminator by Pol II that ignores the 
upstream pA site creates a gene loop that favors termination at the downstream site.  
Non-pA Termination 
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Nrd1 and Nab3 bind specific RNA sequences and act as sensors to detect non-pA 
terminator sequences in the nascent transcript.  While a number of studies have 
characterized the short motifs recognized by Nrd1 and Nab3 the relative orientation and 
abundance of these sequences varies widely among non-pA terminators (Carroll et al., 
2007; Carroll et al., 2004; Creamer et al., 2011; Jamonnak et al., 2011; Porrua et al., 
2012; Schulz et al., 2013; Wlotzka et al., 2011). In this study we have localized 
termination downstream of 49 snoRNAs and 144 CUT transcripts. This has allowed a 
search for sequences that may define these two sets of terminators. We find that the most 
significant motif in this set of snoRNA terminators contains the GUA[A/G] motif 
previously identified for Nrd1 in the context of a longer sequence that indicates the 
possible involvement of another, unidentified RNA-binding protein.  The second most 
significant motif is the Nab3 binding sequence UCUUG. In the case of the CUT 
terminators the only significant motif is the Nab3 binding sequence. Thus, it appears that 
while both Nrd1 and Nab3 binding contribute to recognition of snoRNA terminators 
Nab3 predominates for CUTs.  This does not preclude Nrd1 from playing a critical role in 
termination at these CUTs.  We have previously shown that Nrd1 is necessary for 
termination of the CUT antisense to FMP40 presumably by acting as an adaptor to couple 
the Nrd1-Nab3-Sen1 complex to the elongating Pol II through interaction between the 
Nrd1 CID and the CTD (Arigo et al., 2006b).   
No other significant motifs were observed upstream of these terminators but we 
did observe that the sequences surrounding the termination site are U-rich and contain 
multiple runs of U residues. This is not unexpected for snoRNA downstream sequences 
as intergenic regions are AT-rich in S. cerevisiae.  The U-rich sequences surrounding the 
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termination sites (Figure 9) of antisense CUTs are more significant as these sequences 
occur in the context of a coding region on the opposite strand.  U-rich sequences have 
been shown to form unstable rU:dA base pairs (Huang et al., 2010) and in the hybrid 
binding site of Pol II transcribing the antisense CUT such an unstable hybrid sequence 
may increase the probability of termination (Kireeva et al., 2000; Martin and Tinoco, 
1980). 
In addition to its role in Pol II termination, our data highlight the role Nrd1 plays 
in the turnover of ncRNAs.  Nrd1 depletion by anchor away leads to accumulation of 
readthrough transcripts in 4tU-seq to a much higher degree than observed by our Rpb2-
HTB PAR-CLIP.  We show here by Northern and RT-PCR that after 40 min of Nrd1 
depletion the level of snR13 readthrough transcripts increases over 100-fold.  However, 
after 40 minutes of depletion the amount of readthrough as observed by PAR-CLIP is less 
than 10-fold.  This difference is likely due to an important role for Nrd1 in coupling 
termination to turnover of the completed transcript.  Nrd1 is found in a complex with 
components of the TRAMP and exosome complexes (Vasiljeva and Buratowski, 2006) 
and previous studies have indicated that nrd1 mutants are deficient in RNA turnover 
(Arigo et al., 2006b; Thiebaut et al., 2006; Vasiljeva and Buratowski, 2006).  
Pulse labeling RNA with 4tU was recently used to analyze newly synthesized 
transcripts in a Nrd1 anchor away mutant and this data identified over 1500 Nrd1-
dependent transcripts (Schulz et al., 2013), far more than the number of terminators we 
describe here.  Part of the reason for this discrepancy is that the six-minute pulse used in 
the 4tU-seq protocol is substantially longer than the time needed to synthesize short 
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RNAs. Thus, 4tU-seq over-estimates the effect on termination and may ascribe 
termination functions to cases where the role in turnover is independent of termination.  
Depletion of the DNA/RNA helicase Sen1 has allowed us to place this factor 
squarely in the Nrd1-Nab3 non-pA termination pathway.  We observe readthrough 
transcription downstream of both snoRNAs and CUTs but not downstream of pA sites.  
Pol II does not progress far downstream after Sen1 depletion indicating that this factor 
may act after the allosteric change has occurred. This is consistent with Sen1 acting in 
place of Rat1 to provide the activity that dislodges the paused Pol II (Porrua and Libri, 
2013) and supports previous work showing the difference in the requirement for these 
factors in pA and non-pA termination (Kim et al., 2006).  
The results presented here are summarized in a model shown in Figure 16. We 
have been able to demonstrate a difference in the global effect of depleting different 
components of the yeast termination machinery. These results have been interpreted in 
the context of a two state model for termination in which terminator sequences in the 
nascent RNA trigger assembly of protein complexes that signal to the elongating Pol II to 
decrease its elongation rate and processivity. These anti-processivity factors include 
Pcf11 for pA terminators and Nrd1 for non-pA terminators. Loss of either of these factors 
leads to runaway processive elongation. In contrast, depletion of Ysh1 or Sen1 does not 
block the transition to non-processive elongation but does result in a defect in removal of 
Pol II from the template. For Sen1 this likely occurs through loss of a rho-like function 
(Brow, 2011; Porrua and Libri, 2013) while Ysh1 depletion leads to a lack of cleavage at 
the pA site thereby limiting access of Rat1 and preventing the torpedo mechanism of Pol 
II release (Pearson and Moore, 2013).   
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The data presented here demonstrate that PAR-CLIP analysis of Pol II in living 
yeast cells can define the site of Pol II termination regions and when coupled with 
depletion of termination factors offers an avenue for examining the roles of different 
factors in termination genome-wide. Such experiments will illuminate the variety of 
mechanisms the cell uses to prevent Pol II from transcribing beyond genetically 
determined 3’ boundaries.  
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MATERIALS and METHODS 
Strain Construction 
Yeast strains for anchor away were constructed using the parental strain HHY168 
(Haruki et al., 2008) (Euroscarf #Y40343). RPB2 was C-terminally tagged with an HTB 
(6xHIS, TEV, and Biotin) tag as described previously (Creamer et al., 2011; Tagwerker 
et al., 2006). NRD1, YSH1, and SEN1 were C-terminally tagged with FRB and FRBGFP 
as described in Haruki et al. (Haruki et al., 2008). The SEN1 promotor was replaced with 
the GAL1 promotor using a cassette from pFA6a-kanMX6-PGAL1-HBH (Tagwerker et 
al., 2006).  All strains used in these experiments are listed in Table 4.  
Cell Growth 
Cells were grown in Complete Synthetic Media (CSM) supplemented with 2% glucose or 
galactose and 40 mg/l adenine. For RNA analysis, cells were seeded to an OD600 of 0.1 
from a 5 ml or 50 ml overnight culture. The cells were then incubated at 30°C to an OD600 
of 1. 1 µg/ml of rap (LC laboratories) was then added to the cultures and the cells were 
allowed to grow for the indicated times in the experiment.  For growth curves, a BioTek 
Infinity 2 (BioTek) was used to incubate a 24 well plate containing CSM media with and 
without 1 µg/ml rap (added after 6 hrs of growth) with orbital shaking (Slow, 1 mm 
amplitude).  Cells were diluted to an OD600 of 0.1 per well and an OD600 was measured 
every 10 min for 24 hours.  
RNA Purification and cDNA synthesis 
Total RNA was extracted from yeast with hot acid phenol as previously described 
(Creamer et al., 2011). Strand specific northern blots were done as described previously 
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(Marquardt et al., 2011) with the following modifications. Ultrahyb (Invitrogen) was used 
instead of the described hybridization buffer. Real-time PCR analysis was done on a 
CFX96 instrument (Biorad) in triplicate as described previously (Jamonnak et al., 2011). 
Primers used can be found in Table 5. 
Live Cell Imaging of FRBGFP Strains. 
The strains containing NRD1-FRBGFP, YSH1-FRBGFP, or GALpSEN1-FRBGFP, 
RPB3-TAGRFP were grown to an OD600 of 1 at 30°C. Live cell imaging was done on a 
Deltavision microscope (Applied Precision) as described previously (Rines et al., 2011) 
with the following modification: 1 µg/ml rapamyacin was added to the agarose/media 
pad. Galactose was substituted for glucose with the GALpSEN1-FRBGFP strain. Pictures 
were taken of GFP at 0 mins and 45 mins post rap exposure and 45 mins for RFP. 
Anchor Away and PAR-CLIP 
Cells were grown overnight 30°C in 50 ml of YPD (Yeast Extract Peptone with 2% 
glucose) media. Four 500 ml flasks of sterile cross-linking media (CSM–Ura 
supplemented with 2% glucose, 40 mg/l adenine, 60 µM uracil, and 1 µM biotin were 
seeded to an OD600 of 0.1 and incubated at 30°C until an OD600 of 1.  Crosslinking was 
carried out by the protocol described in Figure 2B.  4-thiouracil (4tU) was added to a 
final concentration of 4 mM and incubated at 30°C for 15 min. 1 µg/ml of rapamycin was 
then added to the cells and incubated at 30°C for 30 min.  All four 500 ml cultures were 
then pooled into one 2 l beaker and irradiated from a distance of two cm with 365 nm UV 
(~ 1 W/cm2) from an LC-L5 LED UV Lamp (Hamamatsu) for 15 min with gentle stirring.  
The top ~2 mm of the culture appears luminescent indicating that the UV light does not 
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penetrate further into the culture. Assuming an even mixture of the culture we calculate 
that the average cell is cross-linked for only ~ 10 seconds within the 15 min crosslinking 
period. The cultures were then filtered through 0.45 micron nitrocellulose filters 
(Millipore) and cells were scraped into 5 ml Buffer 1 (300 mM NaCl, 0.5% NP-40, 50 
mM NaPO4 pH 7.2, 10 mM immidazole, 6 M Guanidine HCl, Protease inhibitor Cocktail 
VII [RPI]) and frozen in liquid nitrogen. 
HTB tagged Rpb2 purification was adapted from our previously published 
protocol (Jamonnak et al., 2011). Cells were lysed in liquid nitrogen using a SamplePrep 
6870 freezer mill (Spex) with 15 cycles per second of cracking for 15 cycles of 1 min 
with 2 min of cooling between each cycle. Lysates were then incubated with 1 ml of Ni-
NTA agarose (Qiagen), which was equilibrated in buffer 1 for 2 hours at room 
temperature. The Ni-NTA agarose was then added to an empty 10 mL plastic column 
(Biorad) and washed with 20 ml of Buffer 1 followed by 10 ml of Buffer 2 (20 mM 
NaPO4 pH 7.2, 300 mM NaCl, 0.5% NP40, 10 mM imidazole, 4 M Urea). The protein 
was eluted off of the Ni-NTA agarose with 5 ml Buffer 2 + 250 mM immidazole and into 
5 ml Buffer 2 + 120 µl Protease inhibitor Cocktail VII + 100 µl of hydrophilic 
streptavidin magnetic beads (NEB). The slurry was allowed to incubate for 4 hours at 
room temperature. The strepavadin magnetic beads were then resuspended in 500 ul of 
Buffer 3 (50 mM Tris pH 7.4, 200 mM NaCl, 4 M Urea), transferred to a 1.5 ml 
siliconized tube and washed with 3 x 1 ml of Buffer 3 followed by 3 x 1 ml of T1 Buffer 
(50 mM Tris pH 7.4, 150 mM NaCl, 2 mM EDTA). Beads were resuspended in 200 µl of 
T1 buffer. 0.15 U/µl of Rnase T1 (Fermentas) was added to the bead slurry and allowed 
to incubate at 25°C for 15 min.  The beads were then washed 3 x 1 ml T1 wash buffer (50 
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mM Tris pH 7.4, 500 mM NaCl, 1% NP-40, 0.5% Na deoxycholate) followed by 3 x 1 ml 
washes in PNK Buffer (50 mM Tris pH 7.2, 50 mM NaCl, 10 mM MgCl2). The beads 
were resuspended in 200 µl of TSAP reaction solution (0.15 U/ul Thermosensitive 
Alkaline Phosphatase [TSAP, Promega], 1 U/µl SupeRase Inhibitor [Invitrogen], 1 mM 
DTT in PNK Buffer) and incubated at 37°C for 30 min. The beads were washed 1 x 1 ml 
Buffer 3, 2 x 1 ml T1 Wash Buffer, and 3 x 1 ml PNK Buffer. 
cDNA Library Preparation 
Streptavadin beads were resuspended in 200 ul of PNK reaction solution (1 U/µl T4 PNK 
[NEB], 32P g-ATP, 5 mM DTT in PNK Buffer) and incubated at 37°C for 30 min. 1 mM 
of cold ATP was added to the reaction and incubated at 37°C for 10 min. The beads were 
washed 1 x 1 ml Buffer 3, 1 x 1 ml T1 wash, 3 x 1 ml T4 RNA Ligase Buffer (50 mM 
Tris pH 7.4, 10 mM MgCl2). The beads were resuspended in 44 µl of T4 RNA Ligase 2 
reaction solution (25% PEG 8000, 5 µM 3’ adaptor 
[AppAGATCGGAAGAGCACACGTCTddC, IDT], 10 U/µl T4 RNA Ligase 2, truncated 
K227Q [NEB], 2 U/µl RNase Inhibitor [Invitrogen], 1 mM DTT in RNA Ligase Buffer) 
and incubated at 25°C for 4 hours. The beads were then washed with 1 x 1 ml Buffer 3 
and 5 x 1 ml T4 RNA Ligase Buffer. The beads were resuspended in 50 ul of T4 RNA 
Ligase reaction solution (5 uM 5’ Adaptor [GUUCAGAGUUCUACAGUCCGACGAUC, 
IDT], 1.2 U/µl RNase Inhibitor, 1mM ATP, 0.5 U/µl T4 RNA Ligase [NEB], 1 mM DTT 
in RNA Ligase Buffer) and incubated at 16°C overnight. The beads were then washed 5 x 
1 ml Proteinase K Buffer (100 mM Tris pH 7.4, 150 mM NaCl, 12.5 mM EDTA). The 
beads were resuspended in 200 µl of Proteinase K Buffer + 2% SDS and 12 µl of 
Proteinase K (NEB). The suspension was incubated for 30 min at 37°C at which point the 
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supernatant was removed and saved and the beads were resuspended in 200 µl of 
Proteinase K Buffer + 2% SDS and 12 µl of Proteinase K. The beads were then incubated 
30 min at 37°C and the supernatants were pooled. The RNA was recovered by acid 
phenol/chloroform extraction followed by two serial ethanol precipitations. The resulting 
pellet was allowed to dry and resuspended in 15 µl of Nuclease-Free Water [Invitrogen]. 
The RNA was split into 5 µL aliquots and frozen at -80°C for storage. 
The Reverse Transcription, PCR, and gel extraction of the cDNA Library were carried 
out as described previously (Jamonnak et al., 2011) with the following modifications. For 
reverse transcription, the primer used was AGACGTGTGCTCTTCCGATCT (IDT). For 
PCR analysis, biological repeats were multiplexed with the following primers. The 
forward primer was 
AATGATACGGCGACCACCGAGATCTACACGTTGAGAGTTCTACAGTCCG*A 
(where a * denotes and phosphorothioate bond).  The first reverse primer was 
CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGTTCAGACGTGTG
CTCTTCGGATC*T for the first biological repeat and the second reverse primer was 
CAAGCAGAAGACGGCATACGAGATTACAAGGTGACTGGAGTTCAGACGTGT
GCTCTTCCGATC*T for the second biological repeat (IDT). 
Sequencing and Bioinformatics 
Sequencing and demultiplexing was done at UC Riverside on an Illumina HiSeq. 
Trimming of the resulting sequences as described previously (Jamonnak et al., 2011). 
Briefly, raw reads were trimmed of the 3’ adaptor using a wrapper for R-bioconductor 
(Gentleman et al., 2004) developed by Sarah Wheelan.  Raw trimmed reads were 
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condensed (defined as no more than one of the same exact sequence) to eliminate any 
PCR artifacts within the data. Bowtie 1.0.0 (Langmead, 2010) was run with the following 
arguments (-y --best -v 2) and aligned to the SacCer3 (R64) genome. Reads mapping to 
tRNA genes were removed as these likely represent artifactual binding during the affinity 
purification steps. Reads were then converted to a wig format where each read was 
multiplied by a factor that was defined as the total number of reads aligned per 107 reads. 
PAR-CLIP datasets have been submitted to GEO with the accession number GSE56435. 
Calculation of the Top 500 PolyA Sites. 
To calculate the best polyA sites per gene we used the sites provided by Moqtaderi et al. 
(Moqtaderi et al., 2013). We set a hard cutoff of at least 200 raw reads. If, however, there 
were multiple very strong polyA sites within 200 base pairs of each other, we calculated 
the read ratio between the two most significant polyA sites. If the read ratio was less than 
0.4, we ignored them. 
Global Readthrough Percentage 
Global readthrough percentage was calculated for each point in the genome as the 
percentage readthrough (reads downstream 500 bp / reads downstream 500 bp + reads 
upstream 500 bp) in the treated sample minus control sample.  All points with a 
percentage readthrough of greater than 10%, at least a total of 1000 reads in either sample, 
and greater reads in the treatment vs the control were extracted. The list was further 
refined by taking the difference of every point 2 kb around non-overlapping termination 
sites (approx 500 total), graphing the region, and then fitting a spline function over a 25 
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bp window to find the best point of inflection.  These points of inflection were then used 
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Figure 1. Nuclear depletion of Pol II termination factors.  
Live yeast cell imaging of: A. NRD1-FRBGFP, RPB3-TAGRFP; B. YSH1-FRBGFP, 
RPB3-TAGRFP; C. GALpSEN1-FRBGFP, RPB3-TAGRFP strains. Time after rap 
treatment is indicated above the pictures. D. Growth of indicated FRB strains on CSM 
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Figure 2. Growth of yeast strains. 
 
 
A. Growth of indicated FRB strains in CSM media with and without rap. OD600 was 
taken every 10 min for 20 hours. The grey bar represents the timeline of the experiment. 
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Figure 3. Comparison of PAR-CLIP biological replicates 
 
A-D. Replicate pair-wise comparison of number of reads corresponding to each gene in 
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Figure 4. Comparison of PAR-CLIP with other datasets. 
 
A-C. Pair wise comparison of number of Rpb2-HTP cross-linked reads in each annotated 
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Figure 5. Verification of readthrough of Pol II after Ysh1 depletion 
 
A-D. Histograms representing normalized reads with Ysh1 (grey) and without Ysh1 
(black) at the given genomic locations. Genes and pA sites are represented below each 
graph and the length of the genome depicted is given in the lower right hand corner. 
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Figure 6. Ysh1 depletion causes readthrough at pA sites. 
A. Mean reads every 10 bp for the 500 most frequently used pA sites with (dotted) and 
without (solid) Ysh1. B. Plot showing percent readthrough of each of 500 pA terminators 
as a fraction of the total 500 pA terminators. C and D.  Histograms representing 
normalized reads with Ysh1 (grey) and without Ysh1 (black) at the given genomic 
locations. The TSS with the direction of transcription is indicated by an arrow.  Genes 
and pA sites are represented below each graph and the length of the genome depicted is 
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Figure 7. Mapping Nrd1-dependent terminators. 
A. Histograms representing of normalized reads for NRD1-FRB with Nrd1 (grey) and 
without Nrd1 (black) at the given genomic locations. The difference between WT and 
Nrd1-depleted at every nucleotide is represented as a histogram below each graph. B.  
Mean reads every 10 bp for 49 snoRNA termination sites showing the highest level of 
readthrough and 144 CUT termination sites with Nrd1 (dotted) and without Nrd1 (solid).  
C. Most abundant Nrd1 motif and the most abundant Nab3 motif in the 150 nt 5’ of the 
snoRNA and CUT terminators, respectively. MEME input parameters were any number 
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Figure 8.  Schulz termination vs PAR-CLIP inflection points 
Relative Position on Schulz et al. termination points compared to our PAR-CLIP 
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Figure 9.  SNR13 termination region 
NET-Seq data from Churchman and Weissman (Churchman and Weissman, 2011) are 
shown above PAR-CLIP data from the SNR13-TRS31 locus. The number of NET-seq 
reads from peaks of Pol II are shown above the lines. The asterisk indicates reads derived 
from mature snR13 RNA that contaminates the NET-seq library. The calculated SNR13 
termination region has been expanded to show U-rich sequences (red) surrounding the 
termination point.  The sequences of several antisense CUT termination regions are 
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Figure 10. Comparison of PAR-CLIP and NET-Seq. 
 
A comparison of NET-Seq data from Churchman and Weissman (Churchman and 
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Figure 11. Nrd1 increases the stability of the readthrough transcripts.  
A. Northern blot and qPCR at different times after addition of rap using the amplicon 
highlighted in red.  B. Histograms representing normalized reads with Nrd1 (grey) and 
without Nrd1 (black) at the given genomic locations. The Y-axis has been changed to 
emphasize the differences between treatment with (black) and without rap (grey) for the 
SNR13-TRS31 locus. C. Similar to A but Schultz et. al. (Schulz et al., 2013) 4tU-seq data 
is also represented in as a histogram below each graph for the same region of the genome 
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Figure 12. Comparison of PAR-CLIP data to Schulz et. al. 4tU-seq data. 
Number of reads for each base pair at the given locus is represented by a histogram. 
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Figure 13. Sen1 depletion causes readthrough at non-pA terminators.  
A.-C.  Mean reads every 10 bp for the top 500 polyA,144 calculated CUT termination 
sites, and 49 snoRNA termination sites, with Sen1 (dotted) and without Sen1 (solid). D. 
Histograms representing normalized reads with Sen1 (grey) and without Sen1 (black) at 
the given genomic locations. The same region is also represented in as a histogram below 
each graph with Nrd1 (grey) and without Nrd1 (black). E. Percent readthrough of non-pA 
terminators (ordered from highest to lowest) represented as a fraction of the total number 
of calculated non-pA terminators. SEN1-FRB is represented as diamonds and NRD1-FRB 
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Figure 14. Pol II Readthrough at Previously Described Sen1 Terminators  
 
 
Histograms representing normalized reads with Sen1 (grey) and without Sen1 (black) at 
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Figure 15. NRD1 and TYE7 Pol II Readthrough. 
 
Histograms representing normalized reads with Nrd1 (grey) and without Nrd1 (black) for 
NRD1 and TYE7. The same region is also represented in as a histogram below each 
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Figure 16. Schematic representation of Pol II termination after removal of non-pA 
and pA termination factors.  
Elongating Pol II (green) terminates pA transcripts (A) after an allosteric change (red) 
that reduces processivity.  (B) Depletion of Ysh1 leads to minimally extended 
readthrough transcripts but does not block the allosteric change in Pol II.  (C) Nrd1 and 
Nab3 binding recruit Sen1 for termination of non-pA transcripts. (D) Pol II elongation 
complex lacking Nrd1 does not recognize termination sequences in the nascent transcript 
and thus does not facilitate the allosteric transition in Pol II. This leads to processive 
readthrough. (E) Nrd1 and Nab3 recognize terminator sequences allowing the allosteric 
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Table 2. Top 266 points of inflection after spline function refinement.  
CUT annotations are defined in Neil et. al.(Neil, 2009). NUT annotations are defined in 
Schulz et. al.(Schulz, 2013). Gene and snoRNA annotations come from the 
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Name Chromosome Inflection Point Strand Percentage Readthrough
CUT382 chrXV 553216 + 43.35
CUT721 chrXI 493135 - 40.80
CUT532 chrIV 1300554 - 39.82
NUT0165 chrIV 1365872 + 38.28
CUT285 chrXIII 130024 + 38.02
CUT088 chrIV 1240442 + 36.75
CUT301 chrXIII 535192 + 34.15
SNR65 chrIII 177261 + 34.10
CUT776 chrXIII 545526 - 33.50
CUT881 chrXVI 117824 - 32.08
CUT160 chrVII 884685 + 31.89
CUT710 chrXI 274705 - 31.84
CUT515 chrIV 892127 - 31.41
CUT110 chrV 262699 + 30.59
CUT216 chrX 582732 + 30.10
CUT075 chrIV 974762 + 29.77
NUT0377 chrX 41790 + 29.51
CUT029 chrII 576557 + 29.13
CUT144 chrVII 484779 + 28.88
CUT645 chrVIII 238387 - 28.61
CUT711 chrXI 286132 - 28.45
NUT0410 chrX 466837 + 28.18
CUT804 chrXIV 185131 - 28.16
CUT620 chrVII 762007 - 27.77
CUT300 chrXIII 501221 + 27.67
CUT114 chrV 348057 + 27.62
CUT335 chrXIV 417868 + 27.51
CUT650 chrVIII 381120 - 27.30
CUT827 chrXV 167567 - 27.00
CUT443 chrII 42768 - 26.68
CUT428 chrXVI 676079 + 26.66
CUT422 chrXVI 475789 + 26.56
CUT913 chrXVI 759202 - 26.55
CUT453 chrII 408165 - 26.53
CUT303 chrXIII 557655 + 26.48
CUT596 chrVII 337383 - 26.40
CUT695 chrX 535071 - 26.38
CUT175 chrVIII 171066 + 26.15
CUT249 chrXII 185193 + 26.08
CUT035 chrII 698509 + 25.96
CUT133 chrVII 229364 + 25.88
CUT271 chrXII 738386 + 25.82
NUT0217 chrV 563133 + 25.80
CUT720 chrXI 387150 - 25.58
NUT1393 chrXV 127850 - 25.51
CUT612 chrVII 667501 - 25.29
CUT723 chrXI 554354 - 25.26
NUT0482 chrXII 66941 + 25.13
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CUT600 chrVII 412769 - 25.00
CUT507 chrIV 703891 - 24.95
CUT808 chrXIV 359108 - 24.93
NUT0447 chrXI 165231 + 24.88
CUT189 chrIX 203808 + 24.82
CUT232 chrXI 335622 + 24.81
NUT0245 chrVII 79377 + 24.57
NUT0828 chrI 224782 - 24.46
CUT825 chrXV 146911 - 24.37
NUT1010 chrVII 94513 - 24.31
CUT396 chrXV 1001332 + 24.23
NUT1273 chrXII 855366 - 24.18
SNR56 chrII 88276 + 23.99
CUT134 chrVII 269569 + 23.99
NRD1 chrXIV 174307 - 23.95
CUT817 chrXIV 529360 - 23.92
CUT781 chrXIII 646742 - 23.81
CUT109 chrV 238837 + 23.70
NUT0473 chrXI 576393 + 23.47
CUT739 chrXII 505509 - 23.24
CUT011 chrII 306412 + 23.18
CUT542 chrV 15700 - 22.95
CUT615 chrVII 702270 - 22.92
NUT1284 chrXIII 46247 - 22.80
SNR60 chrX 349046 - 22.53
CUT363 chrXV 204881 + 22.37
CUT002 chrI 138767 + 22.23
CUT919 chrXVI 874679 - 22.17
CUT742 chrXII 657775 - 22.16
SNR47 chrIV 541515 - 22.14
NUT1194 chrX 611827 - 22.07
NUT0685 chrXV 136420 + 22.07
CUT472 chrIV 99170 - 22.05
CUT241 chrXI 490117 + 21.94
CUT699 chrX 650898 - 21.83
NA chrXI 142916 - 21.82
NUT0422 chrX 620770 + 21.78
CUT207 chrX 186970 + 21.78
NUT0344 chrVIII 294313 + 21.68
CUT655 chrVIII 450388 - 21.63
CUT095 chrIV 1359350 + 21.24
CUT415 chrXVI 352836 + 21.15
CUT880 chrXVI 108077 - 21.09
CUT019 chrII 366035 + 21.09
NUT0472 chrXI 566363 + 20.97
CUT319 chrXIV 168487 + 20.90
CUT536 chrIV 1436562 - 20.79
CUT704 chrXI 96084 - 20.71
NUT1351 chrXIV 355951 - 20.69
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NUT0728 chrXV 617357 + 20.47
CUT566 chrV 416334 - 20.46
CUT082 chrIV 1149859 + 20.45
CUT332 chrXIV 349044 + 20.26
CUT112 chrV 326283 + 19.92
CUT653 chrVIII 441765 - 19.86
CUT439 chrI 35789 - 19.82
CUT724 chrXI 557207 - 19.81
CUT865 chrXV 849041 - 19.67
CUT617 chrVII 739472 - 19.66
CUT225 chrXI 31140 + 19.40
CUT813 chrXIV 459163 - 19.35
NA chrXIII 751946 + 19.32
NUT0906 chrIV 599243 - 19.25
CUT505 chrIV 690295 - 19.09
CUT067 chrIV 588279 + 19.04
CUT669 chrIX 381386 - 19.03
CUT701 chrXI 24572 - 18.99
ARO4 chrII 717921 - 18.97
MSG5 chrXIV 530104 + 18.88
CUT081 chrIV 1106256 + 18.86
SNR45 chrXVI 822033 + 18.86
CUT575 chrVI 118993 - 18.82
NUT0645 chrXIV 307589 + 18.81
CUT049 chrIV 57222 + 18.69
CUT113 chrV 343708 + 18.63
CUT883 chrXVI 131958 - 18.62
SNR49 chrXIV 716354 + 18.60
CUT673 chrX 99146 - 18.56
CUT098 chrIV 1427703 + 18.48
CUT065 chrIV 542766 + 18.46
NUT0846 chrII 533166 - 18.40
NA chrII 235801 - 18.37
MTD1 chrXI 590459 + 18.17
NUT0521 chrXII 500843 + 18.14
SNR34 chrXII 899484 + 18.13
NUT0097 chrIV 264737 + 18.13
NUT0352 chrVIII 461842 + 18.11
CUT092 chrIV 1319619 + 18.06
SNR4 chrV 425029 + 18.04
CUT270 chrXII 721871 + 17.92
CUT806 chrXIV 275679 - 17.92
NUT1180 chrX 380653 - 17.89
NUT0869 chrIII 310523 - 17.82
CUT278 chrXII 1042064 + 17.82
NUT0971 chrV 251351 - 17.76
NA chrXII 827893 - 17.70
NUT0511 chrXII 388840 + 17.70
NUT1125 chrVIII 551396 - 17.68
	   79	  
 
 
NUT0826 chrI 184550 - 17.47
CUT267 chrXII 675014 + 17.46
CUT607 chrVII 576304 - 17.43
NA chrVII 974893 + 17.42
CUT420 chrXVI 454235 + 17.40
SNR46 chrVII 545607 + 17.31
SNR11 chrXIII 652536 + 17.25
SNR87 chrXI 431085 - 17.24
CUT545 chrV 59103 - 17.15
CUT475 chrIV 134699 - 17.15
NUT0379 chrX 74270 + 17.12
NUT0451 chrXI 200721 + 17.04
CUT869 chrXV 953672 - 16.98
SNR62 chrXV 409626 - 16.91
NUT0356 chrVIII 554353 + 16.90
NUT0288 chrVII 767149 + 16.87
CUT587 chrVII 131130 - 16.79
NUT0107 chrIV 387686 + 16.75
CUT405 chrXVI 170206 + 16.73
SNR8 chrXV 832515 + 16.65
SNR35 chrXV 759204 - 16.58
SNR32 chrVIII 381790 + 16.57
CUT259 chrXII 404950 + 16.47
CUT705 chrXI 158166 - 16.44
CUT183 chrVIII 501773 + 16.41
CUT528 chrIV 1269536 - 16.40
CUT188 chrIX 188137 + 16.33
CUT213 chrX 413916 + 16.29
CUT550 chrV 178282 - 16.26
NUT0532 chrXII 645536 + 16.23
NUT0893 chrIV 365847 - 16.18
CUT805 chrXIV 241142 - 16.16
NUT0699 chrXV 343227 + 16.15
SNR48 chrVII 609769 + 15.96
CUT905 chrXVI 622923 - 15.91
CUT340 chrXIV 568559 + 15.88
NUT0558 chrXIII 13774 + 15.85
NA chrVII 559366 + 15.84
CUT823 chrXV 101061 - 15.84
CUT812 chrXIV 434412 - 15.70
NUT0741 chrXV 930774 + 15.68
NUT1077 chrVII 894104 - 15.64
NUT0896 chrIV 443965 - 15.62
CUT260 chrXII 416075 + 15.55
CUT571 chrV 544874 - 15.55
NUT0160 chrIV 1297331 + 15.53
SNR10 chrVII 346294 + 15.25
CUT214 chrX 458662 + 15.21
CUT614 chrVII 671740 - 15.20
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CUT399 chrXVI 41047 + 15.15
TYE7 chrXV 978041 - 15.14
NA chrVIII 385235 + 15.09
NUT0855 chrII 786570 - 15.07
NUT0616 chrXIII 784645 + 15.02
NUT0322 chrVIII 68055 + 14.90
CUT861 chrXV 781423 - 14.89
CUT064 chrIV 502101 + 14.87
NUT1387 chrXV 79594 - 14.85
SNR71 chrVIII 411471 + 14.81
SNR83 chrXIII 626668 + 14.74
KTR2 chrXI 557877 + 14.65
NUT0256 chrVII 320259 + 14.59
GLT1 chrIV 155619 - 14.57
SNR61 chrXII 794287 - 14.54
NUT0053 chrII 615689 + 14.46
CUT374 chrXV 422133 + 14.38
CUT178 chrVIII 198778 + 14.37
NUT1523 chrXVI 882679 - 14.36
HUT1 chrXVI 87231 - 14.32
CUT051 chrIV 163549 + 14.31
NUT1384 chrXV 39983 - 14.22
CUT921 chrXVI 878303 - 14.16
NUT0959 chrV 115713 - 14.01
NUT0841 chrII 391186 - 13.97
CUT066 chrIV 563451 + 13.91
NUT1081 chrVII 958783 - 13.79
CUT744 chrXII 672513 - 13.76
NUT0932 chrIV 1183201 - 13.65
CUT015 chrII 326655 + 13.65
NUT0570 chrXIII 242291 + 13.60
CUT684 chrX 267983 - 13.60
CUT585 chrVII 55979 - 13.38
NUT0243 chrVII 64053 + 13.22
NUT0249 chrVII 173558 + 13.09
ERT1 chrII 699851 - 12.95
SNR13 chrIV 1403164 + 12.79
NUT0361 chrIX 136596 + 12.77
SNR128 chrX 139538 - 12.55
CUT368 chrXV 316180 + 12.50
CUT354 chrXV 22266 + 12.40
OLA1 chrII 291733 - 12.29
NUT0463 chrXI 446937 + 12.24
CUT733 chrXII 265028 - 11.80
NUT0117 chrIV 506605 + 11.75
SNR3 chrX 664097 + 11.73
NUT0942 chrIV 1321655 - 11.50
NUT1325 chrXIII 807785 - 11.48
NUT0363 chrIX 202534 + 11.46

















CUT468 chrIV 22206 - 11.42
SNR30 chrXII 199445 + 11.36
SNR69 chrXI 365002 + 11.35
SNR31 chrXV 841952 - 11.29
NUT0218 chrVI 16922 + 11.27
CUT418 chrXVI 432564 + 11.27
CUT680 chrX 172782 - 11.04
CUT644 chrVIII 231468 - 10.98
KAP95 chrXII 823355 - 10.87
SNR36 chrXV 680685 - 10.85
NUT0861 chrIII 124701 - 10.70
SNR42 chrXI 558935 - 10.54
NUT1114 chrVIII 455034 - 10.48
NA chrXI 317694 + 10.25
NUT0763 chrXVI 95857 + 10.24
NUT0554 chrXII 1002486 + 10.11
SNR82 chrVII 317156 + 9.75
NUT0310 chrVII 1060500 + 9.63
SNR63 chrIV 323229 - 9.01
CUT775 chrXIII 513189 - 7.96
SNR5 chrXV 842699 + 7.81
CUT901 chrXVI 481060 - 4.09
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Table 3. Top 49 points of inflection 3' of snoRNAs after spline function refinement.  
snoRNA annotations come from the saccharomyces genome database. 
 
Name Chromosome Inflection Point Strand Percentage Readthrough
SNR34 chrXII 899483 + 23.42
SNR47 chrIV 541516 - 22.94
SNR65 chrIII 177256 + 20.01
SNR45 chrXVI 822025 + 18.55
SNR4 chrV 425034 + 18.12
SNR56 chrII 88276 + 18.01
SNR49 chrXIV 716317 + 17.44
SNR13 chrIV 1403160 + 17.26
SNR60 chrX 349128 - 17.11
SNR32 chrVIII 381790 + 17.04
SNR35 chrXV 759197 - 16.58
SNR62 chrXV 409624 - 15.68
SNR10 chrVII 346326 + 15.59
SNR46 chrVII 545603 + 15.42
SNR71 chrVIII 411468 + 15.19
SNR48 chrVII 609780 + 13.17
SNR82 chrVII 317151 + 12.87
SNR64 chrXI 39050 + 12.83
SNR61 chrXII 794281 - 12.82
SNR8 chrXV 832499 + 12.71
SNR83 chrXIII 626531 + 12.65
SNR31 chrXV 841956 - 12.38
SNR128 chrX 139535 - 12.18
SNR79 chrXII 348332 - 12.03
SNR3 chrX 664089 + 11.94
SNR30 chrXII 199426 + 11.84
SNR36 chrXV 680692 - 11.58
SNR66 chrXIV 586314 + 11.34
SNR69 chrXI 364951 + 11.10
SNR42 chrXI 558934 - 10.65
SNR63 chrIV 323224 - 10.36
SNR58 chrXV 136035 - 9.97
SNR5 chrXV 842694 + 9.74
SNR85 chrXIII 67783 - 9.71
SNR39B chrVII 366381 - 9.13
SNR43 chrIII 107553 - 8.94
SNR37 chrX 228003 - 8.48
SNR40 chrXIV 89478 + 8.48
SNR87 chrXI 431096 - 8.17
SNR59 chrXVI 173793 + 7.97
SNR67 chrV 61594 + 7.70
SNR161 chrII 307132 - 7.59
SNR53 chrV 61707 + 7.44
SNR50 chrXV 259670 + 7.12
SNR189 chrIII 178587 - 6.87
SNR33 chrIII 142316 - 6.64
SNR81 chrXV 234528 + 5.86
SNR17A chrXV 780654 + 5.44
SNR18 chrI 143034 + 2.60
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HHY168 MATalpha tor1-1 fpr1::NAT RPL13A-2 FKBP12::TRP1
JC2749
MATalpha tor1-1 fpr1::NAT RPL13A-2 FKBP12::TRP1 RPB2-
HTB::KanMX
JC2771
MATalpha tor1-1 fpr1::NAT RPL13A-2 FKBP12::TRP1 RPB2-
HTB::KanMX NRD1-FRB::HIS3
JC2807
MATalpha tor1-1 fpr1::NAT RPL13A-2 FKBP12::TRP1 RPB2-
HTB::KanMX NRD1-FRB::HIS3 /pRS406-NRD1
JC2794
MATalpha tor1-1 fpr1::NAT RPL13A-2 FKBP12::TRP1 RPB2-
HTB::KanMX NRD1-FRBGFP::HIS3 RPB3-TAGRFP::hph
JC2775
MATalpha tor1-1 fpr1::NAT RPL13A-2 FKBP12::TRP1 RPB2-
HTB::KanMX YSH1-FRB::HIS3
JC2770
MATalpha tor1-1 fpr1::NAT RPL13A-2 FKBP12::TRP1 RPB2-
HTB::KanMX SEN1-FRB::HIS3
JC2828
MATalpha tor1-1 fpr1::NAT RPL13A-2 FKBP12::TRP1 YSH1-
FRBGFP::HIS3 RPB3-TAGRFP::hph
JC2834
MATalpha tor1-1 fpr1::NAT RPL13A-2 FKBP12::TRP1 
<KanMX>PgalSEN1-FRBGFP::HIS3 RPB3-TAGRFP::hph
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PCR Amp Fwd 
AATGATACGGCGACCACCGAGATCTACACGTTGAGAGTTCT
ACAGTCCG*A 
PCR Amp Rev 1
CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAG
TTCAGACGTGTGCTCTTCGGATC*T 
PCR Amp Rev 2
CAAGCAGAAGACGGCATACGAGATTACAAGGTGACTGGAG
TTCAGACGTGTGCTCTTCCGATC*T
snr13 qPCR/Northern Fwd CCTGTCTTTCTGTCGCTTCC
snr13 qPCR Rev AGTACGTTGGGTTTGGCTTG
ACT1 qPCR/Northern Fwd GCCTTGGACTTCGAACAAGA
ACT1 qPCR Rev CAAAACCCAAAACAGAAGGA
RPL42A qPCR Fwd GGGTGGTGAAAAGAAGCAAA
RPL42A qPCR Rev TGCAACTGCTTGTCTGGAAA
RPL34A qPCR Fwd GTCAAGGAACAAACCGAAGC
RPL34A qPCR Rev ATTCCCATGGCTATGGATGA
RPL21B qPCR Fwd CTCCAGTTCCATACGAAACCTT
RPL21B qPCR Rev TGAATACCTGCTGAGAAGATGG
RPL24B qPCR Fwd CGCCACTTCCCGTTAAGATA
RPL24B qPCR Rev CGGGTAACGATCATGAACAA
(where a * denotes and phosphorothioate bond)
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ABSTRACT 
 The C-terminal Domain (CTD) of RNA Polymerase II (Pol II) is a major part of a 
regulatory network that links transcription to RNA processing. In Saccharomyces 
cerevisiae, Nrd1 is a transcriptional factor that binds to the CTD and nascent RNA and 
terminates transcription on a variety of specific RNAs. Nrd1 shares homology to the 
proteins RBM16 and SFRS15 in mammalian cells. Photoactivatable-Ribonucleoside-
Enhanced Crosslinking and Immunopreciptiation (PAR-CLIP) has been used to define 
the RNAs that are bound to human RBM16. Of the PAR-CLIP products that were 
purified, non-coding RNAs (ncRNAs), mRNAs, and snoRNAs were the highly 
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INTRODUCTION 
RNA Polymerase II (Pol II) is responsible for the transcription of most protein coding 
genes and some ncRNAs in eukaryotes.  The C-terminal domain (CTD) of Pol II is a 
scaffold to which many proteins bind during each of a transcription cycle (Buratowski, 
2009). The CTD itself is modified to reflect the state of Pol II transcription (Chapman et 
al., 2007; Zhang and Corden, 1991). It is through the “CTD code” of phosphorylation 
states and other post-translational modifications that different factors and complexes can 
bind to influence transcription (Carroll et al., 2007; Nedea et al., 2003). 
 In yeast, the Nrd1-Nab3-Sen1 (NNS) pathway is a complex of proteins involved 
in the attenuation of certain Pol II transcripts (Steinmetz et al., 2001). Nrd1 is a protein 
that interacts with CTD through its CTD interacting domain (CID) and the nascent RNA 
through its RNA recognition motif (RRM).  These two domains define the function of 
this protein. Using homology and looking for a similar protein architecture two other 
related proteins were discovered in higher eukaryotes. These proteins were first referred 
to as SCAF4 and SCAF8, but now they are referred to as RBM16 and SFRS15 
respectfully (Yuryev et al., 1996). Crystallization of the CID from these proteins seems to 
indicate that they interact with the CTD in a very similar manner (Lunde et al., 2010). 
The NNS complex, in yeast, terminates the transcripts of snoRNAs, some 
mRNAS, and cryptic unstable transcripts (CUTs) (Arigo et al., 2006a; Arigo et al., 
2006b; Steinmetz et al., 2001).  Similar to yeast, snoRNA maturation requires the nuclear 
exosome (Berndt et al., 2012) Although an NNS-like pathway has never been found in 
higher eukaryotes, this similarity might suggest a mechanistic conservation. Unlike yeast, 
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C/D box snoRNAs in mammals are mostly found in the introns of genes (Hirose et al., 
2003). This functional difference means that although there may be a similarity between 
Nrd1 and RBM16 on the protein level the mechanism of action would have to be 
different if RBM16 is involved in snoRNA maturation. 
RBM16’s function within the nucleus of mammalian cells is poorly understood. 
Using PAR-CLIP, we have pulled down and purified RNAs that are bound to RBM16. 
Definition of the RNAs purified, might give insight into the possible functions of this 
protein and how it compares to its yeast counterpart Nrd1. Further evidence of similarity 
between types of RNAs bound to both of these factors might translate to a similar 
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RESULTS 
Expression of 6xHis-TEV-Biotin tagged version of RBM16 was done using the 
Invitrogen flp-in Trex system. Correct expression of the tagged RBM16 was verified by 
western blot after treatment with doxycycline for 6, 12, 24, and 48 hours (Figure 17A). 
After 12 hours of doxycycline treatment, expression of RBM16-HTB was approximately 
equal to that of endogenous RBM16 levels (Figure 17A). For cross-linking exeriments, 4-
thiouridine and doxycycline were both added to the cell culture media and allowed to 
incubate with the cells for 12 hours. 
 A single cDNA library preparation was made from the RNA crosslinked to 
purified of RBM16-HTB after treatment.  A 6% polyacrylamide nucleic acid gel showed 
a plethora of PCR amplified cDNA from the purification (Figure 17B). Bioanalyzer 
results indicated that the final cDNA libarary was between 100-150 bps long (Figure 
17C). Notice, that there was minor contamination by primer dimers even after the gel 
extraction. 
 Of the 32,923,767 sequences derived from sequencing the library, only 25,165,211 
sequences had an identifiable 3’ adaptor. After condensing the reads to remove duplicates 
5,402,948 reads were left, of which 367,700 reads aligned to the hg19 genome only twice. 
This is only 6.8 % of the condensed reads and 1.1 % of the total reads before trimming. 
 Within those reads that did align, 273 genes were enriched within the dataset 
(Table 6).  Of note are ncRNAs: Xist, NCRNA00164, and MALAT1 and several protein 
coding genes: HFM1, PDE3A, SLIT2, AUTS2, and SRRM2. Of those genes that had 
aligned reads, most had more reads at the 3’ end of the gene than that 5’ end of the gene 
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(Figure 18). 59 snoRNA loci were also enriched in this dataset (Table 2). Most of these 
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DISCUSSION 
 Expression of a tagged version of RBM16 was the first step to purification and 
elucidation of target RNAs.  The spliced gene for RBM16 is approximately 4kb in length. 
Using Invitrogen’s Flp-in Trex expression system, we were able to incorporate a 
tetracycline/doxycyline inducible HTB tagged version of RBM16 into HEK-293 cells. 
The system uses Flp recombinase, Zeocin susceptibility, and hygromycin resistance to 
guarantee the protein is integrated into the genome. Further testing by western blot 
showed that, indeed, we could get reliable expression of our tagged RBM16 within 12 
hours of treatment with doxycycline (Figure 17A). 
 Using a combination of PAR-CLIP and highly denaturing tandem affinity 
purification, we were able to purify RNAs that were specifically bound to RBM16.  Even 
though the resulting library was sparse in terms of reads that aligned to the genome, we 
were able to identify some RNAs that RBM16 binds. 
 The largest amounts of reads aligned were of RBM16 binding to Xist (Table 6). 
Xist is a non-coding RNA involved in X chromosome inactivation (Maclary et al., 2013). 
Some other ncRNAs were found bound to RBM16 as well. Although the number of reads 
aligned to these ncRNAs were not as significant as Xist, this may point to a role for 
RBM16 in transcriptional control of ncRNAs. Although, Xist and MALAT1 seem to be 
pulled down in most human cell culture PAR-CLIP experiments (Friedersdorf and Keene, 
2014). Other genes with high number of reads aligned were those of protein coding genes. 
Interestingly, of all genes that had as least 10 reads, more reads were found in the 3’ end 
of the genes than the 5’ end of the gene (Figure 18). 
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Of the 59 snoRNA genes that RBM16 binds, 51 are C/D box and 8 are H/ACA 
(Table 7). Most of these C/D box snoRNAs are contained within the introns of protein 
coding genes while H/ACA are processed in a different manner (Berndt et al., 2012; 
Hirose et al., 2003). Perhaps, RBM16 retains some function to regulate the maturation of 
snoRNAs. As the exosome is still conserved in the maturation of snoRNAs, RBM16 may 
act to bridge these two processes. This mechanism, however, would not be through 
transcriptional termination, but an alternative unknown mechanism most likely involving 
the splicing machinery. 
  This dataset hints at the function of RBM16 within the mammalian nucleus. In 
yeast, Nrd1 binds and recruits the nuclear exosome and is required for proper snoRNA 
maturation (Grzechnik and Kufel, 2008; Kim et al., 2006; Vasiljeva and Buratowski, 
2006). It does seem through the pulldown of C/D box snoRNAs RBM16 retains some 
function in the maturation of snoRNA from its yeast homolog Nrd1. Nrd1 is also 
important in controlling pervasive transcription of non-coding RNAs and some mRNAs 
(Arigo et al., 2006a; Arigo et al., 2006b; Creamer, 2011; Thiebaut et al., 2006). It is 
possible that RBM16 is also part of some complex regulating ncRNAs protein coding 
genes, again, through linkage to the nuclear exosome. Although RBM16’s mechanism of 
action could be quite different from that of Nrd1, their final outcome for transcriptional 
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MATERIALS AND METHODS 
Expression of RBM16-HTB in HEK-293 cells 
Knocking in of the HTB tagged version of RBM16 was done using the Invitrogen Flp-In 
TRex system per the manufacturers instructions. Cells that were hygromycin resistant 
were tested by treating with 1ug/ml doxycycline for up to 48 hours and measuring protein 
levels using a western blot as previously described (Figure 17A)  (Creamer, 2011). 
Purification of RBM16-HTB 
HEK-293 cells that expressed RBM16-HTB after doxycycline treatment were grown to 
approximately 90% confluency in 10 100mm cell culture dishes. Cells were treated with 
1ug/ml doxycycline and 4-thiouridine for 12 hours. After treatment, the cells were 
irradiated using a mercury arc-lamp at 365nm for 10s. Further steps taken during 
purification were identical to what has been described previously (Creamer, 2011). 
Library Preparation 
Libraries were made as previously described (Creamer, 2011). Resulting sequences were 
also analyzed as previously described (Schaughency, 2014), but with the following 
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Figure 17. Expression and purification of RBM16-HTB 
A. Western blot of whole cell extracts made from cells treated with doxycycline for the 
indicated times. Top western was probed with an anti-RBM16 antibody and the bottom 
western was probed with an anti-RGS6XHIS antibody. B. 6% polyacrylamide gel of the 
cDNA library after PCR amplification. C. Visual representation of a Bioanalyzer lane 
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Figure 18. Reads that map to the 5’ or 3’ end of each gene 
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Table 6. Genes with RBM16 reads aligned 
List of all genes containing more than 100 reads aligned in order from highest to lowest. 
 
Chromosome Start End Gene Reads Strand
chrX 73040495 73072588 XIST 3051 -
chr1 91726323 91870426 HFM1 991 -
chr2 132905164 133015542 NCRNA00164 724 -
chr12 20522197 20833881 PDE3A 504 +
chr4 20255235 20620788 SLIT2 435 +
chr7 69063905 70257885 AUTS2 384 +
chr16 2802330 2821413 SRRM2 378 +
chr11 65265233 65273940 MALAT1 373 +
chr5 106712590 107006596 EFNA5 359 -
chrX 53559063 53713673 HUWE1 320 -
chr21 34915350 34949812 SON 315 +
chr16 78133551 79246564 WWOX 312 +
chr3 59735036 61237133 FHIT 296 -
chr3 61547243 62280573 PTPRG 294 +
chr10 52750945 54055274 PRKG1 292 +
chr21 38739859 38887679 DYRK1A 282 +
chr1 21132972 21503340 EIF4G3 278 -
chr8 70584575 70747208 SLCO5A1 276 -
chrX 24712056 25015103 POLA1 272 +
chr5 14143829 14509458 TRIO 267 +
chr8 48685669 48872743 PRKDC 263 -
chr6 56322785 56819413 DST 263 -
chr10 34400097 35103923 PARD3 260 -
chr1 237205702 237997288 RYR2 258 +
chr1 205681947 205719361 NUCKS1 252 -
chr6 155054512 155155194 RBM16 252 +
chr2 212240442 213403352 ERBB4 245 -
chr8 118811602 119124058 EXT1 240 -
chr4 30722037 31148421 PCDH7 235 +
chr1 245013602 245027827 HNRNPU 233 -
chr2 140988996 142889270 LRP1B 233 -
chr1 61542946 61928460 NFIA 230 +
chr7 127292202 127732659 SND1 221 +




chr12 1100404 1602697 ERC1 219 +
chr13 34392206 34540695 RFC3 216 +
chr21 32490736 32931290 TIAM1 212 -
chr21 27252861 27543446 APP 211 -
chr6 73331835 73905580 KCNQ5 209 +
chrX 53401070 53449618 SMC1A 208 -
chr19 3976054 3985461 EEF2 206 -
chr11 115044345 115375241 CADM1 204 -
chr10 129894923 129924655 MKI67 201 -
chr9 134305477 134375578 BAT2L1 200 +
chr21 47744036 47865682 PCNT 199 +
chr16 89334035 89556969 ANKRD11 197 -
chr1 171454666 171562650 BAT2L2 196 +
chr22 38879443 38902345 DDX17 195 -
chr5 179125930 179158642 CANX 194 +
chr6 16299343 16761721 ATXN1 194 -
chr22 28374002 29075853 TTC28 190 -
chr1 243651535 244006553 AKT3 190 -
chr1 214776532 214837914 CENPF 189 +
chr7 132937823 133750514 EXOC4 188 +
chr8 10753654 11058875 XKR6 184 -
chr1 35649201 35658743 SFPQ 183 -
chr3 78646390 79639061 ROBO1 182 -
chr5 89854617 90460033 GPR98 182 +
chr7 28338940 28865511 CREB5 181 +
chr6 157099086 157530402 ARID1B 180 +
chr1 19401000 19536746 UBR4 179 -
chr7 111366164 111846462 DOCK4 178 -
chr5 138609792 138666130 MATR3 178 +
chr16 58553855 58663750 CNOT1 177 -
chr4 73940502 74124502 ANKRD17 173 -
chr15 99192761 99507759 IGF1R 173 +
chr20 34291531 34330193 RBM39 172 -
chr7 3341080 4308632 SDK1 172 +




chr7 26229556 26240413 HNRNPA2B1 171 -
chr14 68286509 69062614 RAD51L1 171 +
chr1 39547118 39952789 MACF1 171 +
chr6 100956608 101329224 ASCC3 169 -
chr8 128806779 129113499 PVT1 169 +
chr5 179041179 179050722 HNRNPH1 167 -
chrX 12156585 12740529 FRMPD4 167 +
chr10 70715892 70744279 DDX21 166 +
chr10 7204249 7453450 SFMBT2 163 -
chr1 8412464 8877699 RERE 162 -
chr6 90353231 90529442 MDN1 162 -
chr19 10764937 10803095 ILF3 162 +
chr12 862225 1020618 WNK1 162 +
chr12 116396381 116714991 MED13L 161 -
chr1 233119882 233431459 PCNXL2 160 -
chr1 225117356 225586996 DNAH14 160 +
chr1 31404353 31538564 PUM1 160 -
chr7 110303110 111202347 IMMP2L 159 -
chr1 115259537 115300671 CSDE1 159 -
chr5 58264865 59189621 PDE4D 157 -
chr6 20534688 21231764 CDKAL1 157 +
chr16 70557701 70606201 SF3B3 156 +
chrX 137713734 138287185 FGF13 155 -
chr1 50906935 51425936 FAF1 155 -
chr7 98476113 98610864 TRRAP 153 +
chr6 168227671 168372703 MLLT4 152 +
chr6 124125069 125146786 NKAIN2 151 +
chr3 184032356 184053146 EIF4G1 151 +
chr15 60780483 61521502 RORA 150 -
chr21 33683330 33765312 URB1 150 -
chr17 29421995 29704695 NF1 150 +
chr21 38123189 38362503 HLCS 150 -
chrX 131760038 132095423 HS6ST2 150 -
chr17 56078280 56084707 SFRS1 150 -





chr14 102547075 102606086 HSP90AA1 149 -
chr14 102430865 102517135 DYNC1H1 149 +
chr10 5726801 5806943 C10orf18 149 +
chr17 44107282 44249594 KIAA1267 148 -
chr12 10998448 11324213 PRR4 146 -
chr6 17615269 17706818 NUP153 146 -
chr17 1553923 1588176 PRPF8 146 -
chr2 232319459 232329205 NCL 145 -
chr20 47662838 47713486 CSE1L 144 +
chr10 64926985 65225722 JMJD1C 144 -
chr2 61705069 61765418 XPO1 144 -
chr11 68228199 68382802 SAPS3 143 +
chr1 16174359 16266950 SPEN 143 +
chr12 110719032 110788898 ATP2A2 143 +
chr6 1624041 2245846 GMDS 142 -
chr6 20402137 20493945 E2F3 141 +
chr6 37787307 38122400 ZFAND3 141 +
chr5 36876861 37065921 NIPBL 141 +
chr10 114206756 114578503 VTI1A 140 +
chr13 93879078 95060274 GPC6 139 +
chr12 11033560 11324210 PRH1 139 -
chr17 27582854 27621166 NUFIP2 139 -
chr1 6845384 7829764 CAMTA1 138 +
chr7 101459292 101927250 CUX1 138 +
chrX 84498997 84528368 ZNF711 138 +
chr11 10818593 10830582 EIF4G2 137 -
chr1 91380855 91487671 ZNF644 137 -
chr5 154092462 154197165 LARP1 137 +
chr17 78518625 78940173 RPTOR 137 +
chr9 20344968 20622514 MLLT3 136 -
chr10 126676418 126849624 CTBP2 136 -
chr10 28821427 28909925 WAC 136 +
chr14 21677295 21737638 HNRNPC 135 -
chr6 128289924 128841870 PTPRK 135 -




chr6 79644136 79788011 PHIP 135 -
chr6 35800811 35888956 SRPK1 134 -
chr17 58755172 59470199 BCAS3 134 +
chr16 3775055 3930121 CREBBP 134 -
chr8 26149034 26228646 PPP2R2A 133 +
chr12 54624730 54673915 CBX5 133 -
chr19 36705504 36729676 ZNF146 133 +
chr1 197053257 197115824 ASPM 132 -
chr7 132469623 132766833 CHCHD3 132 -
chr17 64298926 64806862 PRKCA 132 +
chr4 151185594 151936879 LRBA 131 -
chr2 236402736 237034127 AGAP1 131 +
chr18 32073254 32471808 DTNA 131 +
chr16 30710462 30751450 SRCAP 129 +
chr2 32582096 32843966 BIRC6 129 +
chr11 65192517 65207155 NEAT1 129 +
chr3 173116244 174001116 NLGN1 129 +
chr17 35441927 35766902 ACACA 128 -
chr9 94972625 95056038 IARS 128 -
chr17 45727275 45761004 KPNB1 128 +
chr1 2160134 2241652 SKI 128 +
chr7 139044634 139108200 LUC7L2 128 +
chrX 70752933 70795740 OGT 128 +
chr21 35445823 35515334 MRPS6 127 +
chrX 73164159 73290219 NCRNA00183 126 +
chr20 36661948 36720766 RPRD1B 126 +
chr13 39917029 40177356 LHFP 125 -
chrX 40944888 41095832 USP9X 125 +
chr13 60239717 60738119 DIAPH3 125 -
chr21 46188955 46221738 UBE2G2 124 -
chr3 71004736 71633140 FOXP1 124 -
chr20 40031170 40247133 CHD6 124 -
chr7 151832010 152133090 MLL3 124 -
chr22 47158549 47569726 TBC1D22A 124 +




chr7 156931655 157062066 UBE3C 124 +
chr12 14518611 14651697 ATF7IP 124 +
chr5 53180614 53606403 ARL15 124 -
chr11 102980160 103350591 DYNC2H1 124 +
chr17 38544795 38574169 TOP2A 123 -
chr5 10353828 10435491 MARCH6 123 +
chr17 55333931 55757299 MSI2 123 +
chr3 9439403 9519838 SETD5 123 +
chr1 227177566 227505826 CDC42BPA 122 -
chr14 66974125 67648525 GPHN 122 +
chr5 65892176 66463092 MAST4 122 +
chr19 12810008 12834810 TNPO2 121 -
chr10 11047259 11378674 CELF2 120 +
chr21 40557404 40685556 BRWD1 120 -
chr5 145826873 145891069 TCERG1 120 +
chrX 123094475 123236506 STAG2 119 +
chr2 71558889 71662189 ZNF638 119 +
chr6 133562495 133853258 EYA4 119 +
chr5 65440085 65476716 SFRS12 118 +
chr20 61509090 61569274 DIDO1 118 -
chr6 32936437 32949282 BRD2 118 +
chr3 54156693 55108584 CACNA2D3 118 +
chr22 36134783 36424585 RBM9 118 -
chr21 30671220 30734215 BACH1 117 +
chr10 75910965 76469060 ADK 117 +
chr5 60628100 60841999 ZSWIM6 117 +
chr13 96743093 97491812 HS6ST3 116 +
chr13 30083551 30169825 SLC7A1 116 -
chr21 44263204 44299678 WDR4 116 -
chr7 155437203 155574179 RBM33 116 +
chr1 182808451 182856884 DHX9 116 +
chr5 140894588 140998622 DIAPH1 116 -
chr15 93443551 93571237 CHD2 116 +
chr1 236958581 237067281 MTR 115 +




chr4 24529087 24586184 DHX15 115 -
chr3 171757418 172118493 FNDC3B 115 +
chr8 18384813 18871196 PSD3 115 -
chr15 85923871 86292586 AKAP13 115 +
chrX 76760356 77041719 ATRX 115 -
chr3 99536681 99897447 C3orf26 114 +
chr22 33669062 34316416 LARGE 114 -
chr6 111982485 112194627 FYN 114 -
chr10 120794541 120840334 EIF3A 114 -
chr1 225674534 225840845 ENAH 114 -
chr1 236713971 236767814 HEATR1 113 -
chr2 216974020 217071016 XRCC5 113 +
chr21 34106210 34144169 C21orf66 113 -
chr7 104756823 105029341 SRPK2 111 -
chr6 18224400 18264799 DEK 111 -
chr10 114710009 114926073 TCF7L2 111 +
chr10 103544200 103578222 MGEA5 111 -
chr5 31400601 31532282 RNASEN 111 -
chr6 5261584 5771816 FARS2 111 +
chr1 116915836 116947396 ATP1A1 111 +
chr20 8113296 8865547 PLCB1 110 +
chr16 24741049 24837548 TNRC6A 110 +
chr17 8377530 8534036 MYH10 110 -
chr5 32354456 32444844 ZFR 110 -
chr16 53737875 54148381 FTO 110 +
chr3 160117430 160152741 SMC4 110 +
chr5 176560080 176727214 NSD1 110 +
chr6 97590037 97731052 C6orf167 109 -
chr2 29117533 29171080 WDR43 109 +
chr17 60019966 60142643 MED13 109 -
chr21 45432206 45526433 TRAPPC10 108 +
chr5 71403118 71505397 MAP1B 108 +
chr20 13976146 16033842 MACROD2 108 +
chr21 33043313 33104431 SFRS15 108 -




chr22 18270415 18507325 MICAL3 107 -
chr3 50712672 51421629 DOCK3 107 +
chr7 130794855 131181398 MKLN1 107 +
chr3 151985829 152183569 MBNL1 107 +
chr8 9413445 9639856 TNKS 107 +
chr10 98277867 98346809 TM9SF3 107 -
chr6 44796469 45345670 SUPT3H 106 -
chr8 17780366 17887457 PCM1 106 +
chr18 72342919 72777628 ZNF407 106 +
chr12 133200348 133263945 POLE 106 -
chr19 41768391 41813811 HNRNPUL1 106 +
chr11 118307205 118395936 MLL 105 +
chr1 89149922 89301938 PKN2 105 +
chr3 23244784 23632296 UBE2E2 105 +
chr2 54683454 54898583 SPTBN1 105 +
chr3 65339906 66024509 MAGI1 105 -
chr5 72112418 72210215 TNPO1 105 +
chr20 21283942 21370463 XRN2 105 +
chr1 78030190 78148343 ZZZ3 104 -
chr19 10244022 10305755 DNMT1 104 -
chr2 205410516 206480537 PARD3B 104 +
chr10 320130 735608 DIP2C 104 -
chr3 168867270 169381556 MECOM 104 -
chr16 18816175 18937726 SMG1 104 -
chr6 57182422 57513376 PRIM2 104 +
chr17 62494374 62502484 DDX5 103 -
chr20 49506883 49547527 ADNP 103 -
chr9 126141933 126692417 DENND1A 103 -
chr10 855484 931702 LARP4B 103 -
chr17 59759985 59940755 BRIP1 102 -
chr21 45079432 45115960 RRP1B 102 +
chr19 34663352 34720420 LSM14A 101 +
chr6 89319989 89673348 RNGTT 101 -
chr8 131064353 131414217 ASAP1 101 -




chr1 97187175 97280605 PTBP2 101 +
chr4 1873123 1983934 WHSC1 101 +
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Table 7. snoRNAS with RBM16 reads aligned 
List of all snoRNAs containing more that five reads aligned in order from highest to 
lowest. 
 
Chromosome Start End Gene Reads Strand
chr1 45241537 45241610 SNORD55 61 +
chr19 12817263 12817332 SNORD41 53 -
chr17 74554874 74554951 SNORD1C 34 +
chr19 49994164 49994229 SNORD34 32 +
chr19 49993874 49993956 SNORD33 32 +
chr20 2634858 2634932 SNORD110 22 +
chr19 3982505 3982570 SNORD37 20 -
chr11 122929970 122930180 SNORD14C 18 -
chr11 62622764 62622838 SNORD26 16 -
chr22 39715057 39715118 SNORD43 16 -
chr11 62622093 62622167 SNORD28 14 -
chr8 56986398 56986460 SNORD54 14 -
chr16 89627838 89627909 SNORD68 14 +
chr1 173835106 173835166 SNORD44 13 -
chr17 62223438 62223517 SNORD104 13 +
chr20 2637585 2637656 SNORD57 12 +
chr19 49994432 49994517 SNORD35A 12 +
chr1 173836812 173836883 SNORD74 12 -
chr1 28833877 28834083 SNORA73A 11 +
chr2 232325079 232325153 SNORD82 11 -
chrX 135961358 135961430 SNORD61 11 -
chr6 31803040 31803102 SNORD48 11 +
chr3 186502585 186502654 SNORD2 10 +
chr17 7478031 7478165 SNORA48 10 +
chr12 57037464 57037538 SNORD59B 10 -
chr3 52726752 52726828 SNORD69 10 +
chr2 86362993 86363129 SNORD94 10 +
chr1 93302846 93302940 SNORD21 9 +
chr11 62621135 62621204 SNORD30 9 -
chr17 27050448 27050509 SNORD42A 9 +
chr1 45243514 45243584 SNORD38A 9 +
chr17 37009116 37009248 SNORA21 9 -
chr5 180670314 180670376 SNORD95 9 -




chr1 173836017 173836076 SNORD75 9 -
chr19 10218327 10218411 SNORD105 9 +
chr1 28835070 28835274 SNORA73B 8 +
chr19 17973397 17973529 SNORA68 8 +
chr17 7481273 7481409 SNORA67 8 +
chr6 133137941 133138016 SNORD100 8 +
chr15 66795583 66795652 SNORD18A 8 -
chr16 70571908 70572001 SNORD111 8 +
chr11 62623037 62623103 SNORD25 7 -
chr20 47895482 47895560 SNORD12C 7 +
chr16 2205024 2205106 SNORD60 7 -
chr17 7480129 7480276 SNORD10 7 +
chr12 49048165 49048301 SNORA34 7 -
chr7 22896232 22896305 SNORD93 7 +
chr11 62621376 62621440 SNORD29 6 -
chr18 47017653 47017717 SNORD58A 6 -
chr6 31804853 31804916 SNORD52 6 +
chr1 45244062 45244130 SNORD38B 6 +
chr5 180668818 180668889 SNORD96A 6 -
chr16 58593700 58593835 SNORA50 6 -
chr8 33370993 33371096 SNORD13 6 +
chr2 203141154 203141241 SNORD70 6 +
chr1 173835773 173835853 SNORD76 6 -
chr19 51305582 51305678 SNORD88C 6 -
chr2 101889398 101889511 SNORD89 6 -
chr19 10220425 10220516 SNORD105B 6 +
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INTRODUCTION 
 
Loosely conserved regions at the 3’ end of yeast genes contain signals for transcriptional 
termination. These termination regions (or terminators) bind proteins that are part of 
complexes associated with the elongating RNA Polymerase II. In protein-coding genes, 
the CF1 complex binds to these terminators leading to assembly of the cleavage and 
polyadenylation machinery (Kloetgen et al., 2014). Alternatively, Nrd1 and Nab3 
recognize elements downstream of snoRNAs and cryptic unstable transcripts (CUTs) 
(Carroll et al., 2007; Carroll et al., 2004; Creamer, 2011; Steinmetz et al., 2001; 
Steinmetz et al., 2006; Wlotzka et al., 2011) and this leads to the association of a complex 
that contains the DNA/RNA helicase Sen1 (Vasiljeva et al., 2008). Neither of these 
mechanisms of termination has yet to be elucidated. 
 Methods of studying protein-nucleic acid interactions have relied heavily on 
crosslinking. Chromatin immunoprecipitation (CHiP) is commonly used to study DNA-
protein interactions (Barski et al., 2007). The method uses the reversible crosslinking 
reagent formadehyde to purify protein-nucleic acid complexes. For RNA-protein 
interactions, formaldehyde crosslinking leads to high background, because of the non-
specific nature of the chemical reaction. Crosslinking and immunoprecipitation (CLIP) 
uses UV-B to successfully and specifically crosslink protein-RNA complexes. Marrying 
the now inexpensive high throughput sequencing to the CLIP method (HITS-CLIP) 
allows for insights into the functions of many different RNA binding proteins (Darnell, 
2010).  
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To study the Nrd1-Nab3-Sen1 (NNS) termination pathway in yeast, we have 
relied on the Photoactivatable Ribonucleoside enhanced Crosslinking and 
Immunoprecipitation (PAR-CLIP) method (Hafner et al., 2010). This has allowed us to 
further understand the relationship between RNA polymerase II (Pol II) and the non-
poly(A) mediated termination pathway. PAR-CLIP has been used to map all binding sites 
of all three factors across the genome and visualize Pol II readthrough after Nrd1, Sen1, 
and Ysh1 mutation (Creamer, 2011; Jamonnak, 2011) . 
Like HITS-CLIP, PAR-CLIP is a method to specifically crosslink RNA Binding 
Proteins to the RNA (Hafner et al., 2010). It does this through irradiation with 365nm UV 
to a culture of cells that have been treated with 4-thiouracil (4TU) or 4-thiouradine (4SU). 
In yeast, 4TU is easily taken up, converted to UTP and incorporated into total RNA. In 
mammalian cell culture, 4SU is used because of a lack of the correct uracil 
phosphoribosyltransferase (UPRT) to take it up 4TU from the media (Melvin et al., 1978; 
Miller et al., 2009). After incorporation, cells are irradiated with 365nm UV to crosslink 
the thio-residues that have now been included in a vast number of transcripts within the 
transcriptome. This wavelength of UV does not crosslink regular RNA-protein 
complexes. This reduces the background seen in CLIP or HITS-CLIP protocols. 
Unlike formadehyde, the thio crosslink is irreversible and causes trouble for the 
reverse transcriptase. During the reverse transcriptase reaction, the 4TU or 4SU will 
cause a T to C transition in the resulting cDNA (Hafner et al., 2010). Although, harder to 
deal with in the analyses of these sequences, this provides a map of potential binding sites 
on all of the RNAs that were purified in this method.  
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After sequencing, PAR-CLIP has a few computational challenges that have to be 
overcome: Normalization of the reads from different sequencing runs and library 
preparations, visual representation of the sequences after mapping, and incorporating T to 
C transitions into the analysis. We have developed bioinformatic pipelines that try to deal 
with these challenges and lay a general framework for analyses of PAR-CLIP datasets in 
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METHODS  
The first pipeline is used to describe the binding of Nrd1, Nab3, and Sen1 within the 
transcriptome. The second pipeline was used to describe the position of Pol II after 
mutation of Nrd1, Sen1, or Ysh1. The third pipeline was used to describe the binding of 
RBM16 (a Nrd1 homolog) to RNAs in HEK-293 cells. The steps used in each pipeline 
are described below. 
Pipeline 1 (Figure 19) : Nrd1, Nab3 , Sen1-HTB tagged datasets (Creamer, 2011; 
Jamonnak, 2011) 
1. Program: removelinkers.R 
Author: Sarah Wheelan 
Overview:  
This program reads a fasta or fastq file and implements a dynamic matching 
algorithm to locate the adaptors/linkers and split them from the rest of the 
sequence. 
Usage: 
removelinkers.R -i input_file -o output_file_prefix -q fastq (default: T) -l1 
left_linker_outer -l2 left_linker_inner -r1 right_linker_outer -r2 right_linker_inner 
-quart quartile, from 1-4 -int print_intermediates -el1 error_rate_start_l1 
(default:0.1) -el2 error_rate_start_l2 (default:0.1) -er1 error_rate_start_r1 
(default:0.1) -er2 error_rate_start_r2 (default:0.1) 
 
linker schema (XX is non-adaptor sequence): 
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 l1l1l1l1-l2l2l2l2-XXXXXXXXXXXXXXX-r2r2r2r2r2-r1r1r1r1r1 
Note: If there is only one right or left linker, choose either the inner or outer as 
they are equivalent  
Where: 
input_file  : fasta or fastq sequence file 
output_file : prefix for the files of trimmed sequences 
fastq : T=fastq file, F=fasta file 
left_linker_outer : 5'-most linker 
left_liner_inner : second 5' linker inside outer linker 
  right_linker_outer : 3'-most linker 
  right_linker_inner : second 3' linker inside outer linker 
quartile : which quartile of the file to work on, to break up big files; no 
entry means do the whole file 
print_intermediates : should all intermediate trimmed reads be saved in 
separate files, or only the end product? (default = T) 
error_rate_start_l1 : starting value for the dynamic error rate for l1 linker 
 (default = 0.1) 
error_rate_start_l2 : starting value for the dynamic error rate for l2 linker  
(default = 0.1) 
error_rate_start_r1 : starting value for the dynamic error rate for r1 linker  
(default = 0.1) 
error_rate_start_r2 : starting value for the dynamic error rate for r2 linker  
(default = 0.1) 
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Example:  
removelinkers.R –i sequences.fastq –o trimmedsequences_1_ –r2 
XXXXXXXXXXXXX(3’ adaptor sequence) –quart 1  
2. Program: rmshortseqraw13.pl 
Author: Paul Schaughency 
Overview:  
This program reads a raw sequence file and prints out only those sequences that 
are longer than 13 nucleotides long. 
Usage: 
rmshortseqraw13.pl –i input_file –o output_file 
Example: 
rmshortseqraw13.pl –i sequences.raw –o sequences>13.raw 
3. Program: Bowtie 
Author: (Langmead et al., 2009) 
Overview: 
A short read alignment program that uses the Burrows-Wheeler transform to 
efficiently map short reads to any genome. 
Usage: 
See (Langmead et al., 2009) 
	   126	  
Example: 
For 4a,b,c:  bowtie –v 1 SacCer2 –m 1 –sam—nohead 
For 4d: bowtie –v1 SacCer2 –m 1  
4a.  Program: SCfixwig.pl 
 Authors: Paul Schaughency, Tyler Creamer 
Overview: Takes a sam output file from bowtie and converts it into a wig file 
used by visualization programs. It does not multiply reads to normalize them. 
Instead it counts 1 read as 1 read. 
Usage:  
SCfixwig.pl -i input sam file -p output plus wig file name -m output minus wig 
file name 
Example: 
SCfixwig.pl -i alignedsequences.sam -p treatmentplusstrand.wig -m 
treatmentminusstrand.wig 
4b. Program: SCfixwigwithmulti.pl 
 Authors: Paul Schaughency, Tyler Creamer 
Overview: Takes a sam output file from bowtie and converts it into a wig file 
used by visualization programs. It normalizes all reads to 107 reads by calculating 
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first a multiplier to apply to all reads then counting each read as a fraction of that 
multiplier.  The multiplier is defined as the number of reads aligned/107 . 
Usage:  
SCfixwigwithmulti.pl -i input sam file -p output plus wig file name -m output 
minus wig file name 
Example: 
SCfixwigwithmulti.pl -i alignedsequences.sam -p treatmentplusstrand_norm.wig -
m treatmentminusstrand_norm.wig 
4c. Program: extractsamSC.pl 
 Author: Paul Schaughency 
Overview: Splits a samfile into two files: one for the plus strand reads and one for 
the minus strand reads. Keeps the sam format for both files. 
Usage:  
extractsamSC.pl < Any Sam File 
Example: 
extractsamSC.pl < Alignedreads.sam 
4d. Program: SCT2C.pl 
 Author: Paul Schaughency 
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Overview: Takes a raw bowtie output file and converts it into a wig file used by 
visualization programs.  This program only counts T to C transitions. 
Usage:  
SCT2C.pl -i rawbowtie file -p output plus wig file name -m output minus wig file 
name 
Example: 
SCT2C.pl -i alignedsequences.rawbowtie -p treatmentplusstrand_T2C.wig -m 
treatmentminusstrand_T2C.wig 
 
5.  Program: binmappingv8.pl 
 Author: Paul Schaughency 
Overview: Using a known annotation file and a two samfiles of plus and minus 
strand reads, can bin reads into any number of bins to figure out the distribution of 
reads within a given annotation. 
Usage:  
binmappingv8.pl [Gene Sorting Options] -g Custom Gene List -p input sam file -
m input sam file -o output name 
            [Gene Sorting Options]  
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-h  sort and check for overlap in genes that have high transcription (txn > or 
= 6) 
-d  sort and check for overlap in genes that have mid range transcription 
(txn < 6 > 3.3) 
-l  sort and check for overlap in genes that have low transcription (txn < or 
= 3.3) 
            -a  sort and check for overlap in all genes 
-c  sort and check for overlap in a custom gene list (if this is defined you 
must also define -g)  
            [Input Files] 
            -g  Custom Gene List 
             Note: Must be a text file the following format:  
Gene_Name <tab> Chromosome <tab> Gene Start <tab> Gene End 
            -p  Sorted Plus Strand Sam File 
            -m  Sorted Minus Strand Sam File 
            -o  Base Name for all Output File 
Example: 
binmappingv8.pl –c –g geneannotation.txt –p plusstrandalignments.sam –m 
minusstrandalignments.sam –o output.txt 
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Pipeline 2 (Figure 20) : Nrd1 Anchor Away, Rpb2-HTB datasets (Schaughency, 2014) 
1&2. See Pipeline 1 
3.  Program: collapserawreads.pl 
Author: Paul Schaughency 
Overview: Takes a raw bowtie output file and collapses all reads that are exactly 
the same into only one read. 
Usage:  
collapserawreads.pl –i input_file –o output_file 
Example: 
collapserawreads.pl –i rawsequences.raw –o collapsedrawsequences.raw 
4.  Program: Bowtie 
Note: See pipeline 1 step 3 
Example: 
For 5a,b: bowtie –v 2 SacCer3tRNA –m 1 –sam—nohead –best –strata -y 
For 5c: bowtie –v 2 SacCer3tRNA –m 1 –best –strata –y 
5.  Program: AlignedMinusExtract.pl 
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Overview: Converts the unread reads from bowtie and puts them back into a 
format so they can be used again to align to the genome. 
Usage:  
AlignedMinusExtract.pl –i input_file –o output_file 
Example: 
AlignedMinusExtract.pl –i tRNAunmappedreads.raw –o 
tRNAunmappedfinal.raw 
6.  Program: Bowtie 
Note: See pipeline 1 step 3 
Example: 
For 5a,b: bowtie –v 2 SacCer3 –m 1 –sam—nohead –best –strata -y 
For 5c: bowtie –v 2 SacCer3 –m 1 –best –strata –y 
7a.  Program: SCFullReadWigNoMulti.pl 
 Authors: Paul Schaughency 
Overview: Takes a sam output file from bowtie and converts it into a wig file 
used by visualization programs. It does not multiply reads to normalize them. 
Instead it counts 1 read as 1 read. Every point across the entire read is counted. 
Usage:  
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SCFullReadWigNoMulti.pl -i input sam file -p output plus wig file name -m 
output minus wig file name 
Example: 
SCFullReadWigNoMulti.pl -i alignedsequences.sam -p treatmentplusstrand.wig -
m treatmentminusstrand.wig 
7b. Program: SCFullReadWigWithMulti.pl 
 Authors: Paul Schaughency 
Overview: Takes a sam output file from bowtie and converts it into a wig file 
used by visualization programs. It normalizes all reads to 10^7 reads by 
calculating first a multiplier to apply to all reads then counting each read as a 
fraction of that multiplier. Every point across the entire read is counted. 
Usage:  
SCFullReadWigWithMulti.pl -i input sam file -p output plus wig file name -m 
output minus wig file name 
Example: 
SCFullReadWigWithMulti.pl -i alignedsequences.sam -p 
treatmentplusstrand_norm.wig -m treatmentminusstrand_norm.wig 
7c. Program: SCT2CV2.pl 
 Author: Paul Schaughency 
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Overview: Takes a raw bowtie output file and converts it into a wig file used by 
visualization programs.  This program only counts T to C transitions and counts 
multiple T to C transitions in one read as separate entities 
Usage:  
SCT2CV2.pl -i rawbowtie file -p output plus wig file name -m output minus wig 
file name 
Example: 
SCT2CV2.pl -i alignedsequences.rawbowtie -p treatmentplusstrand_T2C.wig -m 
treatmentminusstrand_T2C.wig 
8.  Program: wig2bedv2.pl 
 Author: Paul Schaughency 
 Overview: Converts wig file format to bed file format. 
 Usage: wig2bedv2.pl –i input_file –o output_file 
 Example: wig2bedv2.pl –i alignedsequences.wig –o alignedsequences.bed 
9.  Program: globalreadthroughv3.pl 
 Author: Paul Schaughency 
Overview: Calculates the global readthrough percentage for each base in the 
entire genome. Outputs percentage wig and bed files. 
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Usage: globalreadthroughv3.pl –a input bed file 1 –b input bed file 2 –c input bed 
file 3 –d input bed file 4 –x nucleotides upstream –y nucleotides downstream –z 
read cutoff  
Example: Usage: globalreadthroughv3.pl –a plusstrandcontrol.bed –b 
minusstrandcontrol.bed –c plusstrandtreatment.bed –d minusstrandtreatment.bed 
–x 500 –y 500 –z 1000  
 
Pipeline 3 (Figure 21) : RBM16-HTB Dataset 
1-3. See Pipeline 2 
4.  Program: Bowtie 
 Note: See pipeline 1 step 3 
Example: 
For 5a: bowtie –v 2 hg19tRNAs –m 1 –sam—nohead –best –strata -y 
For 5b: bowtie –v 2 hg19tRNAs –m 1 –best –strata –y 
5.  Program: AlignedMinusExtract.pl 
Note: See pipeline 2 step 5 
6.  Program: Bowtie 
 Note: See pipeline 1 step 3 
Example: 
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For 5a: bowtie –v 2 hg19 –m 1 –sam—nohead –best –strata -y 
For 5b: bowtie –v 2 hg19 –m 1 –best –strata –y 
7a. Program: HGFullReadWig.pl 
 Authors: Paul Schaughency 
Overview: Takes a sam output file from bowtie and converts it into a wig file 
used by visualization programs. It does not multiply reads to normalize them. 
Instead it counts 1 read as 1 read. Every point across the entire read is counted. 
Usage:  
HGFullReadWig.pl -i input sam file -p output plus wig file name -m output minus 
wig file name 
Example: 
HGFullReadWig.pl -i alignedsequences.sam -p treatmentplusstrand.wig -m 
treatmentminusstrand.wig 
7b. Program: HGT2CV2.pl 
 Author: Paul Schaughency 
Overview: Takes a raw bowtie output file and converts it into a wig file used by 
visualization programs.  This program only counts T to C transitions and counts 
multiple T to C transitions in one read as separate entities 
Usage:  
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HGT2CV2.pl -i rawbowtie file -p output plus wig file name -m output minus wig 
file name 
Example: 
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DISCUSSION 
The goal with any analyses like these is to try to accurately map all RNAs bound to these 
RNA binding factors. As described previously, PAR-CLIP was used to make cDNA 
libraries from factors tagged for highly denaturing tandem purification. The results of the 
sequencing of these libraries were large files containing millions of reads all 32bp – 50 
bp long. 
 The first step in analyzing any library is to try to remove any sequences pertaining 
to the 3’ adaptor. When libraries are made, adaptors are ligated at the 5’ and 3’ end of the 
RNA of interest. These adaptors allow for the reverse transcription, PCR amplification, 
and sequencing of these RNAs. The Illumina sequencing primer ends at the end of the 
end of the 5’ adaptor. Therefore, none of the 5’ adaptor should be present in the final 
sequencing reads. The 3’ adaptor, although, will be present because we size selected for 
small insert sizes.  
 There are many ways to go about trimming the 3’ adaptor from the sequencing 
reads. The most basic idea is to search for any part of the 3’ adaptor and to eliminate it 
from the sequences. This is quite effective, but because the accuracy of the Illumina 
machine to incorporate the correct base decreases from 5’ to 3’, many reads may be 
thrown out accidentally. An open-source R package called Bioconductor (Gentleman et 
al., 2004) has been developed and contains a slightly better algorithm for 3’ adaptor 
removal. In brief, it uses a heuristic to allow for mismatches closer to the 3’ end of the 
read. Dr. Sarah Wheelan wrote an easy to use interface for this program, which we used 
in all for all of our datasets. 
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 After trimming the sequences, depending on the amount of sequences that are 
trimmed, the reads can be condensed. Condensing the reads is defined as counting all 
exact duplicate reads as only one read. There are two reasons that reads could be the 
same. First, they were amplified from the same cDNA or, alternatively, they came from 
two different RNAs crosslinked in the same manner. Although, the latter is certainly 
possible, the former is a bigger concern. The presence of the T to C transitions caused by 
the incorporation of 4tU as well as the RNase T1 step of the library preparation point 
toward there being exact duplicate reads more from PCR amplification bias.  
 Bowtie is an efficient short read alignment program (Langmead et al., 2009). In 
the first experiments with PAR-CLIP, bowtie was used to conservatively align the reads 
to the current yeast genome (SacCer2). These reads were allowed only one mismatched 
base and only one unique alignment. In subsequent experiments, the reads were allowed 
to contain two mismatched bases and one non-unique alignment. The main difference 
between the first PAR-CLIP experiments and the subsequent ones was the change from 
32bp reads to 50 bp reads. Allowing for only one mismatched base was deemed too 
conservative because of the amount of T to C transitions that could be sequenced with a 
longer read. This required a rewrite of all downstream programs in order to compensate 
for the extra information. The switch from one unique alignment to one non-unique 
alignment was done to try and alleviate the concern that some reads were being discarded 
because they were too repetitive. It is unclear whether switching from unique to non-
unique would be helpful for future datasets. 
 Starting with the anchor away data sets, reads that mapped to tRNAs were 
removed from every dataset by running bowtie against a pseudogenome of all tRNAs in 
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yeast (or human) and then taking those reads that do no align and using those for 
subsequent analyses (AlignedMinusExtract.pl). Even with highly denaturing tandem 
affinity purification, we have seen reads map to tRNAs in every dataset (data not shown). 
Whether or not this is significant has yet to be determined, but for the data sets in 
question this was considered background. 
 After alignment, all datasets need to be normalized for any usable computational 
algorithm (SCfixwig.pl, SCfixwigwithmulti.pl, etc.) . For this, the simplest method of 
normalization was chosen; to adjust all read counts to that of the total reads aligned per 
107 reads. This generally puts all reads within the same range on a per experiment basis. 
One caveat is that the number of mapped reads number within an experiment should be 
generally close to begin with or else the algorithm tends to over estimate certain data sets 
over others.  All of our datasets within all experiments were close enough together for 
this to work. Other normalization techniques, as described before, could work to alleviate 
this problem, but, because some depend on assumptions that changes to transcription do 
not happen to a vast majority of transcripts, these would not necessarily be better. 
 The datasets, also, needed to be converted to a format so that they could be 
analyzed visually as well as computationally. The file formats used was .wig and .bed. 
Both file formats are fairly similar with major difference being that in a .wig file the 
chromosome header contains the chromosome number for all data points after that header 
while the .bed format contains the chromosome number in each line. The only other 
minor difference is that the .bed file format has a column dedicated to strandedness (plus 
or minus strand) while the .wig file format does not. This requires .wig to have a separate 
file for plus (Watson) strand reads and minus (Crick) strand reads. Since the 
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normalization happens during conversion to a wig file, sometimes the wig files had to be 
converted back to .bed file for computational reasons. 
 In the first set of PAR-CLIP experiments, the subsequent wig files were made 
using the midpoint of the read rounded down. If all reads were treated this way, then it 
should give an accurate map of approximately where the reads were crosslinked. A more 
accurate, but less robust way of finding crosslink sites was to only map T to C transitions. 
The downside of this, although it was able to get us binding motifs, was that there were 
much less reads to work with when you confine it to just T to C transitions. In subsequent 
analyses of PAR-CLIP experiments, we opted to represent every bp of the reads that 
mapped. This was important in order to accurately map readthrough of Pol II. 
 It is from here that the analyses of the individual experiments differ in terms of 
computational output.  Most likely, programs used in a particular dataset will not be 
applicable to most PAR-CLIP datasets. It is worth noting, however, that the ideas behind 
these programs might still be usable in a different context.  
 Of note from the first pipeline, are the division of genes into bins and the counting 
of reads into the plus and minus strand of each bin. This was done by dividing a gene into 
a number of user defined segments, then, annotating an array of numbers each 
representing 1bp on each chromosome to define each bin. This came with the caveat that 
no two genes could overlap in the same direction or within the 5’ or 3’ UTR region 
defined by the user. This was not a problem for the gene annotation dataset used for this 
project because gene overlap was rare. For larger custom gene annotation lists this could 
eliminate too many genes from the analysis. Once all genes had defined bins all reads 
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were then counted that fell within each bin for each gene. Averaging these gene bins, 
then, was a simple computational task. 
 Within the anchor away dataset analysis, the calculation of percentage 
readthrough was unique. Similar to calculating a traveling ratio, percentage readthrough 
takes the difference of the percent of reads downstream of a point within the genome. 
This difference comes from percentages calculated from the treatment versus the control 
datasets. When calculated for every base in the yeast genome, it illuminates potential 
readthrough sites for the Nrd1 anchor away dataset. The Nrd1 anchor away dataset, 
though, is unique in that the readthrough is pretty long. The percentage readthrough 
calculation has trouble with datasets with shorter readthroughs (Sen1, Ysh1).  
Optimization of the calculation of percentage readthrough could alleviate this problem.  
Despite this caveat, the percentage readthrough calculation was able to accurately predict 
termination regions when the readthrough extended sufficiently downstream (Nrd1). 
 PAR-CLIP is a powerful method that can elucidate many unique and interesting 
interactions between RNA and protein within the cell. We have successfully used this 
method to describe the interactions of the Nrd1-Nab3-Sen1 termination pathway and 
RNA Pol II. We have had to develop many different bioinformatic pipelines in order to 
analyze the subsequent datasets. Taken together these pipelines can act as guidance for 
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Figure 19. Nrd1, Nab3, Sen1 –HTB pipeline 
A schematic diagram of the bioinformatic pipeline used to analyze libraries made from 
purifying Nrd1, Nab3, Sen1 – HTB in yeast. Where there is an arrow, the output of the 
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Figure 20. Nrd1, Sen1, Ysh1 anchor away pipeline 
A schematic diagram of the bioinformatic pipeline used to analyze libraries made from 
purifying Rpb2-HTB after mutation of Nrd1, Sen1, or Ysh1 in yeast. Where there is an 
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Figure 21. RBM16-HTB pipeline 
A schematic diagram of the bioinformatic pipeline used to analyze libraries made from 
purifying RBM16-HTB in HEK-293 cells. Where there is an arrow, the output of the 
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Specialty Coursework: 
Developmental Biology  2009  Johns Hopkins School of Medicine 
Membrane Trafficking   2009  Johns Hopkins School of Medicine 
Great Experiments in Biology 2009  Johns Hopkins School of Medicine 
HIV Biology    2009  Johns Hopkins School of Medicine 
Programming In Perl*  2011  Johns Hopkins School of Public  
       Health 
Introduction to Effective Instruction  2012  Johns Hopkins School of Education 
Transcription Mechanisms  2012  Johns Hopkins School of Medicine 
Drug Discovery Case Studies  2012  Johns Hopkins School of Medicine 
Epigenetics    2013  Johns Hopkins School of Medicine 
 
*denotes a course that was audited 
Laboratory Experience: 
Thesis research 2009-2014 Lab of Dr. Jeffry Corden  Johns Hopkins 
SoM 
Identified novel termination points for the Nrd1-Nab3 termination pathway genome wide 
using PAR-CLIP. This involved rapid conditional depletion of different termination 
factors from the nucleus using rapamycin followed by specific crosslinking to 4-
thiouracil containing RNA bound to proteins. Sequencing was done on the purified RNA 
and specific bioinformatic pipelines to analyze the data were made. 
 
Research Rotation 2008-2009 Lab of Dr. John Lorsch  Johns Hopkins 
SoM 
Examined the effects of the yeast consensus sequence on translation in vivo and in vitro 
 
Research Rotation 2008-2009 Lab of Dr. Geraldine Seydoux Johns Hopkins 
SoM 
Examined whether or not expression of 3’UTR GFP fusions in  c. elegans males are 
viable. 
 
CRTA Fellow  2006-2008 Lab of Dr. Howard Young  NCI-Frederick 
Investigated IL-15 control of bid expression in primary human natural killer cells. 
 
Summer Internship 2005  Lab of Dr. Paul Smith   UMBC 
Worked on synthesizing a novel napthanol analog of UK-1 as potential Topoisomerase 
and HIV-1 Integrase inhibitor. 
 
Senior Project  2004-2006 Lab of Dr. Edward Orlando  St. Mary’s 
College 
Worked on treating the hermaphroditic Rivulus marmoratus with ethinyl estradol to try to 
direct the development of true females. 
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Termination Sites. Molecular Biology and Genetics Departmental Research Colloquium. 
Johns Hopkins School of Medicine, Baltimore, MD (speaker) 
Schaughency P (2009-2013) Presented and discussed many different interesting papers. 
Molecular biology and genetics journal club. Johns Hopkins School of Medicine, 
Baltimore, MD (speaker) 
Schaughency P, Merran J, Corden J (2013) Anchoring Away Nrd1: Elucidating the Role 
of Non-Poly(A) Mediated Termination in Saccharomyces cerevisiae. Biochemistry, 
Cellular, and Molecular Biology Retreat. Johns Hopkins School of Medicine, Baltimore, 
MD (poster) 
Schaughency P, Creamer T, Jammonak N, Darby M, Corden J (2010) RBM16: a Nrd1-
like attenuator of Pol II transcription? Biochemistry, Cellular, and Molecular Biology 
Retreat. Johns Hopkins School of Medicine, Baltimore, MD (poster) 
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and Molecular Biology Retreat. Johns Hopkins School of Medicine, Baltimore, MD 
(poster) 
 
Service and Leadership: 
 
Student Mentor, Johns Hopkins School of Medicine.   2008-Present 
Assisted Dr. Jeffry Corden with the supervision of an undergraduate student, a graduate 
rotation student, a technician, and an individual looking for some wet lab experience. 
Taught correct laboratory safety and techniques, and helped their professional 
development. 
Biochemistry Lab Assistant, St. Mary’s College of Maryland.  2005-2006 
Worked with Dr. P. Mertz to prepare various solutions and gels for use in an 
undergraduate biochemistry laboratory. Oversaw and assisted with many biochemistry 
lab classes. 
